VIII.- BIBLIOGRAFÍA.
(1)
AMERICAN PSYCHIATRIC ASSOCIATION (1980). Diagnostic and statistical manual of
mental disorders (3rd edn)(DSM-III).
Washington, DC:APA.
(2) SCHATZBERG,
A.F.(1991) Overview of anxiety disorders: prevalence, biology, course, and
treatment. Journal of Clinical Psychiatry, 52 Suppl, 5‑9.
(3)
LÓPEZ-IBOR J.J., SÁIZ J., Y MORAL L.(1988) The fenfluramine challenge test in
the affective spectrum: A possible marker of endogeneity and severity.
Pharmacological Psichiatry, 21, 14.
(4)
AMERICAN PSYCHIATRIC ASSOCIATION (1987). Diagnostic and statistical manual of
mental disorders (3rd edn Revised). Washington, DC: APA.
(5) WORLD
HEALTH ORGANIZATION (1992) International Classification of Diseases, Tenth
Revision. World Health Organization.
(6) WORLD
HEALTH ORGANIZATION (1990). International Classification of Diseases, Draft for
Tenth Revision. World Health Organization. BUSCAR ICD-10.
(7)
BARLOW, D.H. (1988) Classification . In Anxiety and its Disorders. The nature
and Treatment of Anxiety and Panic, pp. 319-355. The Guilford Press.
(8)
LOPEZ-IBOR ALIÑO J.J.(1988) Problemas para la clasificación de los trastornos
de angustia. Actas Luso-españolas de Neurología Psiquiatría y ciencias afines,
16, suplemento 1, 11-16.
(9)
DACOSTA J.M. (1871) On irritable heart: A clinical study of a form of
functional cardiac disorder and its consequences. American Journal of The
Medical Sciences, 61, 17.
(10) LEWIS
T. (1917) Medical Research Committe: Report upon soldiers returned as cases
of"disordered action of the
heart" or "valvular disease of the heart". London: His Majesty's
Stationery Office.
(11) COHEN
M.E., BADAL D.W., KILPATRICK A., REED E.W. & WHITE P.D. (1951) The high
familial prevalence of neurocirculatory asthenia (anxiety neurosis, effort
syndrome). American Journal of Human Genetics, 3, 126-158.
(12) LEVIN
K.(1978) Freud's Early Psychology of the Neuroses. A Historical
Perspective.University of Pittsburgh Press, Pittsburgh (traducido al castellano
en 1985 por el Fondo de cultura económica)
(13) FREUD
S.(1962). Obsessions and phobias: Their psychical mechanism and their
aetiology. In J. Strachey (Ed and Trans.). The Standard edition of the complete
psychological works of Sigmun Freud (Vol.3) London: Hogarth Press. (Original
work published 1895)
(14) KLEIN
D.F.(1983) Replay to panic attacks in phobia treatment studies. Archives of
General Psychiatry, 40, 1151-1152.
(15) LEWIS
A.J.(1934). Melancholia: a historical review. Journal of Mental Science 80,
1-42.
(16)
POLLITT, J. & YOUNG, J. (1971)
Anxiety state or masked depression? A study based on the action of
monoamine oxidase inhibitors. British Journal of Psychiatry, 119, 143‑149.
(17) LÓPEZ
IBOR, J.J.(1950) La angustia vital. Paz Montalvo. Madrid.
(18) LÓPEZ
IBOR, J.J.(1966) Las Neurosis como enfermedades del ánimo. 1966. Editorial
Gredos.
(19)
KLEIN, D.F. & FINK, M.(1962) Psychiatric reaction patterns to imipramine.
American Journal of Psychiatry, 119, 432-438.
(20)
PITTS, F.N. & McCLURE, J.N.(1967) Lactate metabolism in anxiety neurosis,
New England Journal of Medicine, 27, 1328-1336.
(21) WORLD
HEALTH ORGANIZATION (1978) Mental Disorders: Glossary and Guide to their
Classification in Accordance with the Ninth Revision of the International
Classification of Diseases. Geneva: World Health Organization.
(22)
TWAROG, B.M. & PAGE, I.H. (1954): Am. J. Physiol., 175, 157-161. Citado por
Carlsson, A. (1987) Monoamines of the Central Nervous System: A Historical
Perspective. En Psychopharmacology. The Third Generation of Progress. edited by
HY. Meltzer. pp. 39-48. New York: Raven Press.
(23)
PEROUTKA, S.J.(1987) Serotonin Receptors. In Psychopharmacology: The Third
Generation of Progress, edited by Herbert Y. Meltzer.pp 303-311. Raven Press,
New York.
(24)
TARGUM, S.D. & MARSHALL, L.E.(1989) Fenfluramine Provocation of Anxiety in
patients With Panic Disorder. Psychiatry Research, 28, 295-306.
(25) POLS,
H. & GRIEZ, E.(1988) Serotonin in panic anxiety. Acta Psichiatrica Belgica,
88, 162-172.
(26)
AZMITIA, E.C., BUCHAN, A.M. & WILLIAMS, J.H. (1978) Structural and
functional restoration by collateral sprouting of hippocampal 5‑HT axons.
Nature, 27, 374‑376.
(27)
GERSHON, M.D., DREYFUS, C.F., PICKEL, V.M., JOH, T.H. & REIS, D.J. (1977)
Serotonergic neurons in the peripheral nervous system: identification in gut by
immunohistochemical localization of tryptophan hydroxylase. Proceedings of the
National Academy of Sciences of the USA, 74, 3086‑3089.
(28) NUTT,
D.J. & GEORGE, D.T. (1990) Serotonin and anxiety. In. Handbook of anxiety,
Vol 3 (ed. G.D. Burrows, M. Roth & R. Noyes, Jr.), pp.189-221. Elsevier
Science Publishers B.V.
(29)
COOPER, J.R, BLOOM, F.E. & ROTH, R.H. (1978) Serotonin. En The biochemical
basis of neuropharmacology. Oxford University Press.
(30)
RALEIGH, M.J. (1987) Differential behavioral effects of tryptophan and
5-hydroxytryptophan in vervet monkeys: influence of catecolaminergic systems.
Psychopharmacology, 93, 44.
(31) PEREZ
DE LOS COBOS, J. (1989) Fototerapia: ¿Una nueva forma de tratamiento en la
depresión?. Symposium Avances en patología depresiva.
(32)
GREEN, R.A. (1978) The cerebral regulation of 5-hydroxytryptamine synthesis and
metabolism in relation to functional physiological effects. In Serotonin in
Mental Abnormalities (ed. D.J.Boulin), pp 72. Wiley. New York.
(33)
GREEN, A. & GRAHAME/SMITH, D.(1978) Processes Regulating the Functional
Activity of Brain 5-Hydroxytryptamine: Results of Animal Experimentation and
Their Relevance to the Understanding and Treatment of Depression.
Pharmacopsychiatry, 11, 3-16.
(34) GOTH,
A.(1981). Medical Pharmacology (10nd edn) (ed. & Mosby Company), pp
255-263.
(35)
LOPEZ-IBOR, J.J. Jr.(1988) The involvement of serotonin in Psychiatric disorder
and behaviour. British Journal of Psychiatry, 153, suppl 3, 26-39.
(36)
IVERSEN, O.H.(1982) Volvolon: A recently discovered peptide hormone from the
pineal body. Canadian Medical Association Journal, 1, 787-790.
(37)
JOUVET, M. & RENAULT, J.(1966) Insomnie persistant aprés lésions des noyaux
du raphé chez le chat. Cmoptes Rendus des Séances de la Societé de Biologie,
160, 1461.
(38)
IDZIKOWSKI, C., COWEN, P.J., NUTT, D.J. & MILLS, F.J. (1987) The effects of
chronic ritanserin treatment on sleep and the neuroendocrine response to
L-tryptophan. Psychopharmacology, 93, 416.
(39)
DEAKIN, J.F.W.W. & DOSTROVSKY, J.O.(1978) Involvement of the periaqueductal
gray matter and spinal 5-hydroxytryptaminergic pathways in morphine analgesia:
effects of lesions and 5-hydroxytryptamine depletion. Br. J. Pharmacol., 63,
159.
(40)
BLUNDELL, J.E.(1984) Serotonin and appetite. Neuropharmacology, 23, 1537-1551.
(41)
MELTZER, H.Y. & LOWY, M.T.(1987) The serotonin hypothesis of depression.In
Psychopharmacology, The Third Generation of Progress(ed & H.Y. Meltzer),
pp.513-526. New York. Raven Press.
(42)
BAUMGARTEN, H.G. & LACHENMAYER, L.(1985) Anatomical features and
physiological properties of central serotonin neurons. Pharmacopsychiatry, 18,
180-187.
(43) FULLER,
R.W.(1986) Biochemical pharmacology of the serotonin system. Advances in
Neurology, 43, 469-480.
(44)
LOPEZ-IBOR, J.J. Jr. (1991) The functional approach of biological research in
Psychiatry. Acta Neurochirurgica, suppl 52, 149-153.
(45)
SOUBRIE, P.(1986) Reconciling the role of central serotonin neurons in human
and animal behaviour. Behavioural and Brain Sciences, 9, 319.
(46)
ROBERTS, M.H., & STRAUGHAN, D.W.(1967) Excitation and depression of
cortical neurones by 5‑hydroxytryptamine. Journal of Physiology, 193,
269-294.
(47)
HAIGLER, H.J. & AGHAJANIAN, G.K. (1974) Peripheral serotonin antagonists:
failure to antagonize serotonin in brain areas receiving a prominent
serotonergic input. Journal of Neural Transmission, 35, 257-273.
(48)
PEROUTKA, S.J. & SNYDER S.H. (1979) Multiple serotonin receptors:
differential binding of (3H) serotonin, (3H) lysergic acid diethylamide, and
(3H) spiroperidol. Molecular Pharmacology, 16, 687-699.
(49)
PEROUTKA, S.J., SLEIGHT, A.J., McCARTHY, B.G., PIERCE, P.A., SCHMIDT, A.W. et
al.(1989) The clinical utility of pharmacological agents that act as serotonin
receptors. Journal of Neuropsychiatry 1, 253-262.
(50)
PEROUTKA, S., LIEBOVITZ, R. & SNYDER, S. (1982) Two distinct central
serotonin receptors with different physiological functions. Science 212,
827-829.
(51) CONN,
P.J. & SANDERS-BUSH, E. (1987). Central serotonin receptors: effector
systems, physiological roles and regulation. Psychopharmacology, 92, 267-277.
(52)
SANDERS-BUSH, E. (1988) 5-HT receptor coupled to phosphoinositide hydrolysis.
In The serotonin receptors (ed. & Sanders-Bush E.), pp 181-198. Humana
Press. New Jersey.
(53)
SPROUSE, J.S. & AGHAJANIAN, G.K.(1987) Electrophysiological responses of
serotoninergic dorsal raphé neurons to 5-HT1A y 5HT1B agonists. Synapse, 1,
3-9.
(54)
TRABER, J. & GLASER, T.(1987) 5-HT1A receptor-related anxiolysis. Trends in
Pharmacological Sciences, 8, 432.
(55)
GOODWIN, G.M. & GREEN, A.R. (1985): Br. J. Pharmacol., 84, 743-753. Citado
por AGHAJANIAN, G.K., SPROUSE, J.S. & RASMUSSEN, K.(1987) Physiology of the
Midbrain Serotonin System. In Psychopharmacology: The Third Generation of
Progress (ed & H.Y. Meltzer), pp 141-149. Raven Press. New York.
(56)
FOZARD, J.R.(1987) 5-HT: The enigma variations. Trends in Pharmacological
Sciences, 8, 501.
(57)
GLENNON, R.A.(1986) Central serotonin agonists and antagonists. In:
Neurotransmissions, Vol II, No. 1, Research Biochemicals Inc., Wayland, MA.
(58)
HOYER, D., PAZOS, A., PROBST, A. & PALACIOS, J.M. (1986) Serotonin receptors
in the human brain. I. Characterization and autoradiographic localization of
5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain
Research, 376, 85.
(59)
YAGALOFF, K.A. & HARTIG, P.R. (1985) Stabilization and characterization of
the serotonin 5-HT1C site from pig choroid plexus. Molecular Pharmacology, 29,
120.
(60) CONN,
P.J. & SANDERS-BUSH, E. (1987) Central serotonin receptors: Effector
systems, physiological roles and regulation. Psychopharmacology, 92, 267.
(61) LÜBBERT,
H., HOFFMAN, B.J., SNUTCH, T.P., VAN DYKE, T., LEVINE, A.J., HARTIG, P.R.,
LESTER, H.A. & DAVIDSON, N. (1987) cDNA cloning of a serotonin 5-HT1C
receptor by electrophysiological assays of mRNA-injected xenopus oocytes.
Proceedings of the National Academy of Sciences of the USA, 84, 4332-4336.
(62)
PEROUTKA, S.J., LEBOVITZ, R.M. &
SNYDER, S.H. (1981) Two distinct serotonin receptors with different
physiological functions. Science, 212, 827.
(63)
HOYER, D.(1988) Molecular pharmacology and biology of 5-HT1C receptors. Trends
in Pharmacological Sciences, 9, 89.
(64)
DESHMUKH, P.P., YAMAMURA, H.I., WOODS, L. & NELSON, D.L.(1983) Computer‑assisted
autoradiographic localization of subtypes of serotonin 1 receptors in rat
brain. Brain Research, 288, 338‑343.
(65)
BARABAN, J.M. & AGHAJANIAN, G.K. (1980) Suppression of firing activity of 5‑HT
neurons in the dorsal raphe by alpha‑adrenoceptor antagonists.
Neuropharmacology, 19, 355‑363.
(66)
AGHAJANIAN, G.K., SPROUSE, J.S. & RASMUSSEN, K.(1987) Physiology of the
Midbrain Serotonin System. In Psychopharmacology: The Third Generation of
Progress (ed & H.Y. Meltzer), pp 141-149. Raven Press. New York.
(67)
WURTMAN, R.J. HEFTI, F. & MELAMED, E. (1980) Precursor control of neurotransmitter synthesis. Pharmacological
Reviews, 32, 315‑335.
(68) NEFF,
N.H. & NECKERS, L.M. (1981) Evidence for neuronal feedback regulation of
serotonin formation in brain. Advances in Experimental Medicine and Biology,
133, 445-453.
(69)
MELTZER, H.Y. (1989) Serotonergic Dysfunction in Depression. British Journal of
Psychiatry, 155, suppl.8, 25-31.
(70)
FERNSTROM, J. & WURTMAN, R.(1972) Brain serotonin content: Physiological
regulation by plasma neutral amino acids. Science, 415-416.
(71)
FERNSTROM, J.D., & FALLER, D.V. (1978) Neutral amino acids in the brain:
changes in response to food ingestion. Journal of Neurochemistry, 30,
1531-1538.
(72) YOUNG
G.A., YULE A.G., HILL G.L. (1983) Effects of an anabolic steroid on plasma
amino acids, proteins, and body composition in patients receiving intravenous
hiperalimentation. Journal of parenteral and enteral Nutrition, 7, 221-225.
(73)
MUNRO, H.N. (1970) Control of synthesis of retained and secreted liver proteins
in relation to amino acid supply. En Plasma protein turnover (eds. R.Bianchi R,
et al.) Baltimore, Univ Park Press, 1976.
(74)
MOLLER, S.E., KIRK, L., & HONORE, P. (1980) Relationship between plasma
ratio of tryptophan to competing amino acids and the response to L-tryptophan
treatment in endogenously depressed patients. Journal of Affective Disorders,
2, 47-59.
(75)
BRUNELLO, W., BARBACCIA, M.L., CHUANG, D.M. & COSTA, E. (1982) Down
regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permisive role of
serotonergic axons. Neuropharmacology, 21, 1145.
(76)
GREEN, A.R. & NUTT, D.J.(1985) Antidepressants. En Psychopharmacology (eds.
D.G. Grahame-Smith & P.J. Cowen), 2, p.4. Elsevier, Amsterdam.
(77)
COWEN, P.J., GRAHAME-SMITH, D.G., GREEN, A.R. & HEAL, D.J. (1982)
Beta-Adrenoceptor agonist enhance 5-hydroxytryptamine-mediated behavioural
responses. Br. J. Pharmacol., 76, 265.
(78)
NIMGAONKAR, V.L., GREEN, A.R., COWEN, P.J., HEAL, D.J., GRAHAME-SMITH, D.J.
& DEAKIN, J.F.W. (1983) Studies on the mechanisms by which clenbuterol, a
beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases
metabolism of 5-HT in the brain of the rat. Neuropharmacology, 22, 739.
(79)
GREEN, A.R., GRAHAME-SMITH, D.G.(1976). Propranolol inhibits the behavioural
responses of rats to increased 5-hydroxytryptamine in the nervous system.
Nature, 262, 594.
(80) WISE,
D.C., BERGER, B. & STEIN L.(1972) Benzodiacepines: anxiety-reducing
activity by reduction of serotonin turnover in the brain. Science, 117,
181-183.
(81) WANG,
R.Y. & AGHAJANIAN, G.K. (1978) Collateral inhibition of serotonergic
neurones in the rat dorsal raphe nucleus: pharmacological evidence.
Neuropharmacology, 17, 819-825.
(82)
SAWYER, S.F., TEPPPER, J.M., YOUNG, S.J. & GROVES, P.M. (1985) Antidromic
activation of dorsal raphe neurons from neostriatum: physiological
characterization and effects of terminal autoreceptor activation. Brain
Research, 332, 15-28.
(83)
LANGER, S.Z. (1987) Presynaptic Regulation of Monoaminergic Neurons. In
Psychopharmacology: The Third Generation of Progress (ed & H.Y. Meltzer),
pp 151-157. Raven Press. New York.
(84)
CHARIG, E.M.(1986) L-trytophan and prolactin release. Evidence for interaction
between 5-HT1 and 5-HT2 receptors. Human Psychopharmacology, 1, 93-97.
(85)
GARDNER, C.R.(1986) Recent developments in 5-HT related pharmacology of animal
models of anxiety. Pharmacology, Biochemistry and Behaviour, 24, 1479-1485.
(86)
MARAZZITI, D., ROTONDO, A., PLACIDI, G.F., PERUGI, G., CASSANO, G.B. & PACIFICI, G.M. (1979) Sex differences in
fetal sheep adrenal steroidogenesis. International Journal of Gynaecology and
Obstetrics, 17, 3‑5.
(87)
MARAZZITI,D., ROTONDO, A.,PLACIDI, G.F., PERUGI, G., CASSANO, G.B. &
PACIFICI, G.M.(1988) Binding of imipramine to platelet membranes is reduced in
panic attacks. Fundamental and Clinical Pharmacology, 2, 69-75.
(88)
BANKI, C.M., MOLNOR, G.(1981) Cerebrospinal fluid 5-hydroxiindoleacetic acid as
an index of central serotonergic processes. Psychiatry Research, 5, 23-32.
(89)
ORELAND, L., WIBERG, A., ASBERG, M., TRÄSKMAN, L., SJÜSTRAND, L., THOREN, P.,
BERTILSSON, L. & TYBRING, G. (1981): Platelet MAO activity and monoamine
metabolites in cerebrospinal fluid in depresses and suicidal patients and in
healthy controls. Psychiatry Research, 4, 21-9.
(90)
LANGER, S.Z., GALZIN, A.M., LEE, C.R. & SCHOEMAKER, H. (1986)
Antidepressant binding sites in brain and platelets. In Antidepressants and
Receptor Function. Ciba Found Symp 123, 3-29.
(91)
LINGJAERDE, O.(1977) Platelet uptake and storage of serotonin, In Serotonin in
health and disease, vol 4, Spectrum Publications, Inc.
(92)
PLETSCHER, A.(1981) Platelets as models for monoaminergic neurons. In Essays in
Neurochemistry and Neuropharmacology, vol 3 (eds. Youhim et al).
(93)
RAISMAN, R., BRILEY, M.S. & LANGER, S.Z. (1979) Specific tricyclic
antidepressant binding sites in rat brain. Nature 281, 148-150.
(94) PAUL,
S.M., REHAVI, M., SKOLNIK, P. et al. (1984). High affinity binding of
antidepressants to biogenic amine transport sites in human brain and platelet: studies
in depression. In Neurobiology of Mood Disorders (eds R.M. Post & J.C.
Ballenger). Baltimore, London: Williams & Wilkins.
(95)
LANGER, S.Z., GALZIN, A.M., POIRIER, M.F., LOO, H., SECHTER, D. & ZARIFIAN,
E. (1987) Association of [3H]-imipramine and [3H]-paroxetine binding with the
5-HT transporter in brain and platelets: relevance to studies in depression.
Journal of Receptor Research, 7, 499-521.
(96)
LARUELLE, M., VANISBERG, M.A. & MALOTEAUX, J.M. (1988). Regional and
subcellular localization in human brain of [3H] paroxetine binding, a marker of
serotonin uptake sites. Biological Psychiatry, 24, 299-309.
(97) VAN
PRAAG, H., LEMUS, C., KAHN, R. (1987) Hormonal probes of central serotonergic
activity: Do they really exist?. Biological Psychiatry, 22, 86-98.
(98)
SIEVER, L.J. Role of Noradrenergic Mechanisms in the Etiology of the Affective
Disorders. En Psychopharmacology, The
Third Generation of Progress. edited by HY. Meltzer. pp. 493-504. New York:
Raven Press.
(99)
REDMOND, D.E. (1977) Alterations in the function of the nucleus locus
coeruleus: A possible model for studies of anxiety. In Animal Models in
Psychiatry and Neurology (ed. I.Hanin & E. Usdin). Pergamon Press. Oxford.
(100)
LIBET, B., FEINSTEIN, B., GLEASON, C.A. (1986) Stimulation of locus ceruleus in
man via chronically implanted electrodes. Society for Neuroscience Abstracts,
12, 1162.
(101)
ISAACSON, R.L.(1982) The Limbic System, second edition, Plenum Press, New York.
(102)
HORVATH, F.E.(1963) Effects of basolateral amygdalectomy on three types of
avoidance behavior in cats. Journal of Comparative and Physiological
Psychology, 56, 380.
(103)
PELLEGRINO, L.(1968) Amygdaloid lesions and behavioral inhibition in the
rat.Journal of Comparative and Physiological Psychology, 56, 814.
(104)
REDMOND D.E.(1979) New and old evidence for the involvement of a brain
norepinephrine system in anxiety. In Phenomenology and Treatment of Anxiety
(eds W.E. Fann, I.Karacan, A.D. Pokorny et al). SP Medical and Scientific
Books. New York.
(105)
CHARNEY, D.S., HENINGER, G.R. & STENBERG, D.E.(1984) Serotonin function and
mechanism of action of antidepressant treatment: effects of amitriptyline and
desipramine. Archives of General Psychiatry, 41, 359-365.
(106)
FLOREZ, J,ARMIJO, J.A., MEDIAVILLA, A. (1987). Transmisión catecolaminérgica.
Fármacos catecolaminérgicos. En Farmacología Humana, tomo 1 (Ediciones
Universidad de Navarra S.A.), pp.145-165.
(107)
KAHN, R. & WESTENBERG, H. (1985) L-5-Hydroxytryptophan in the Treatment of
Anxiety Disorders. Journal of Affective Disorders, 8, 197-200.
(108)
ROUSSEL, B., BUGUET, A., BOBILLIER, P. & JOUVET, M. (1967) Locus coeruleus,
sommeil paradoxal, et noradrenaline cerebrale. Comptes Rendus des seances de la
societe de biologie et de ses filiales, 161, 2537‑2541.
(109)
CHOUINARD, G., ANNABLE, L., FONTAINE, R., & SOLYOM, L.(1982) Alprazolam in
the treatment of generalized anxiety and panic disorders: a double blind
placebo- controlled study. Psychopharmacology(Berlin), 77, 229-232.
(110)
SHEEHAN, D.V., COLEMAN, J.H., GREENBLATT, D.J., JONES, K.J., LEVINE, P.H.,
ORSULAK, P.J., PETERSON, M., SCHILDKRAUT, J.J., UZOGARA, E. & WATKINS, D.
(1984) Some biochemical correlates of panic attacks with agoraphobia and their
response to a new treatment. Journal of Clinical Psychopharmacology, 4, 66-75.
(111)
ALEXANDER, D.E., ALEXANDER, D.D. (1984) Alprazolam treatment for panic
disorder. Presented at the 137 th Annual Meeting at the American Psychiatric
Association. Los Angeles.
(112)
LYDIARD,R.B., LARAIA,M.T., BALLENGER,J.C. & HOWELL,E.F. (1987) Emergence of
depressive symptoms in patients receiving alprazolam for panic disorder.
American Journal of Psychiatry, 144, 664‑665.
(113)
BREIER, A., CHARNEY, D.S., HENINGER, G.R. (1985) The diagnostic validity of
anxiety disorders and their relationship to depressive illness. American
Journal of Psychiatry, 145, 787-797.
(114)
ERIKSSON, E.(1987) Brain neurotansmission in panic disorder. Acta Psychiatrica
Scandinavica Supplementum, 335, 31-37.
(115)
KUNOS, G. & FARSANG, C. (1981) Beta-endorphin:Possible involvement in the
antihypertensive effect of central alpha-receptor activation. Science, 211,
82-84..
(116)
VALLEJO, J. & DÍEZ, C. (1990) Etiopatogenia. En Trastornos Afectivos:
Ansiedad y Depresión (Salvat Editores S.A.). Barcelona.
(117)
ERIKSSON, E., WESTBERG, P., THURESSON, K., MODIGH, K., EKMAN, R., &
WIDERLÖV E.(1989) Increased Cerebrospinal Fluid Levels of Endorphin
Immunoreactivity in Panic Disorder. Neuropsychopharmacology, 2, 225-228.
(118)
LIEBOWITZ, M.R., GORMAN, J.M., FYER, A.J., DILLON, D.J. & KLEIN, D.F.
(1984) Effects of naloxone on patients with panic attacks. American Journal of
Psychiatry 141, 995-997.
(119)
COHEN, M.R., COHEN, R.M. & PICKAR, D. (1983) High dose naloxone infusions
in normals. Dose dependent behaviora, hormonal and physiological responses.
Archives of General Psychiatry, 40, 613-619.
(120)
BEAL, J.F., UHL, G., MAZUREK, M.F., KOWALL, H., MARTIN, J.B. (1986)
Somatostatin: alterations in the central nervous system in neurological
diseases. In Neuropeptides in neurologic ans psychiatric disease (eds. J.B.
Martin, J.D. Barchas) pp, 215-257. New York: Raven Press.
(121)
RUBINOW, D.R.,POST,R.M., DAVIS, C.L., DORAN, A.R. (1987) Somatostatin and GHRH:
mood and behavioral regulation. Advances in Biochemical Psychopharmacology, 43,
137-152.
(122)
GERNER, R.H. & YAMADA, T. (1982) Altered neuropeptide concentrations in
cerebroespinal fluid of psychiatric patients. Brain Research, 238, 298-302.
(123)
REICHLIN, S. (1981) Control de la secreción de la hipófisis anterior. En
Tratado de Medicina Interna de Cecil, traducción 16ª edición en inglés, pp
1216-1222. Interamericana.
(124)
GARCÍA SEVILLA, J., MAGNUSSON, T. & CARLSSON, A. (1978) Effect of
intracerebroventricularly administered somatostatin on brain monoamine
turnover. Brain Research 155, 159-164.
(125)
GOLD, P.W. & RUBINOW, D.R. (1987) Neuropeptide Function in Affective
Illness: Corticotropin-Releasing Hormone and Somatostatin as Model Systems. En
Psychopharmacology: The Third Generation of Progress (ed. H.Y.Meltzer), pp.
617-627. Raven Press. New York.
(126)
TANAKA, S., & TSUJIMOTO, A. (1981)
Somatostatin facilitates the serotonin release from rat cerebral cortex,
hippocampus and hypothalamus slices. Brain Research, 208, 219-222.
(127)
GOTHERT, M. (1980) Somatostatin selectively inhibits noradrenaline release from
hypothalamic neurones. Nature, 288, 86-88.
(128)
ROBERTS, G.W., CROW, T.J., & POLAK, J.M. (1985) Location of neuronal
tangles in somatostatin neurones in Alzheimer's diseaseNature 314, 92-94.
(129)
NEGRO-VILAR, A., OJEDA, S.R., ARIMURA, A., & McCANN, S.M. (1978) Dopamine
and norepinephrine stimulate somatostatin release by median eminence fragments
in vitro. Life Sciences, 23, 1493-1498.
(130)
REICHLIN, S.(1981). In Neurosecretion and Brain Peptides (ed by J.B. Martin, S.
Reichlin, & K.L. Bick), pp. 573-597. Raven Press, New York.
(131)
ANTON, R.F., BALLENGER, J.C., LYDIARD, R.B., LARAIA, M.T., HOWELL, E.F. &
GOLD, P.W. (1989) CSF prostaglandin‑E in agoraphobia with panic attacks.
Biological Psychiatry, 26, 257‑264.
(132)
CARR, D.B., SHEEHAN, D.V., SURMAN, O.S., COLEMAN, J.H., GREENBLATT, D.J.,
HENINGER, G.R., JONES, K.J., LEVINE, P.H., WATKINS, W.D. (1986) Neuroendocrine
correlates of lactate induced anxiety and their response to chronic alprazolam
theraphy. American Journal of Psychiatry, 143, 483-494.
(133)
ANTON R.F. (1990) Prostaglandins: Relationship to the Central Nervous System
and the Platelet in Panic Disorder. In Neurobiology of Panic Disorder, pp
349-363. Alan R. Liss, Inc.
(134)
HOKFELT, T., JOHANSSON, O., GOLDSTEIN, M. (1984) Chemical anatomy of the brain
. Science, 225, 1326.
(135)
GRAY, T.S. (1987). Autonomic neuropeptide connections of the amygdala. In
Neuropeptides and Stress (eds Y.Tache, J.E. Morley & M.R. Brown).
Springer-Verlag, New York.
(136)
FONE, K.C., JOHNSON, J.V., BENNETT, G.W. & MARSDEN CA (1989). Involvement
of 5-HT2 receptors in the behaviours produced by intrathecal administration of
selected 5-HT agonists and the TRH analogue (CG 3509) to rats. British Journal
of Pharmacology, 96, 599-608.
(137)
STEWART, R.S., DEVOUS, M.D., RUSH, J.A., LANE, L., BOUTE, F.J., (1988) Cerebral
blood flow changes during sodium-lactate-induced panic attacks. American
Journal of Psychiatry, 145, 442-449.
(138)
REIMAN, E.M., RAICHLE, M.E., ROBINS, E., BUTLER, F.K., HERSOVITCH, P., FOX, P.
& PERLMUTTER, J. (1986) The application of positron emission tomography to
the study of panic disorder. American Journal of Psychiatry, 143, 469-477.
(139)
WHEELER, E.O., WHITE, P.D., REED, E.W., & COHEN, M.E. (1950).
Neurocirculation asthenia(anxiety neurosis effort syndrome, neurasthenia): a
twenty-year follow-up study of one hundred and seventy-three patients. Journal
American Medical Assistance, 142, 878-888.
(140)
KELLY, D., MITCHELL-HEGGS, N. & SHERMAN, D. (1971). Anxiety and the effects
of sodium lactate assessed clinically and physiologically. British Journal of
Psychiatry, 119, 129-141.
(141)
LIEBOWITZ, M.R., FYER, A.J., GORMAN, J.M., DILLON, D., APPLEBY, I., LEVY, G.,
ANDERSON, S., LEVITT, M., PALIJ, M., DAVIES, S., NAD KLEIN, D.F. (1984) Lactate
provocation of panic attacks:I. Clinical and behavioral findings. Archives of
General Psychiatry, 41, 764-770.
(142)
COWLEY, D.S., DAGER, S.R. & DUNNER, D.L. (1986) Lactate‑induced panic
in primary affective disorder. American Journal of Psychiatry, 143, 646‑648.
(143)
SANDBERG, D.P., HARRISON, W., GORMAN, J.M., NEE, J. & ENDICOTT, J. (1987)
Sodium lactate vulnerability in premenstrual dysphoria. Preceedings ACNP,
Puerto Rico.
(144)
ZITRIN, C.M., KLEIN, D.F., WOERNER, M.G., & ROSS, D.C. (1983) Treatment of
Phobias. I. Comparison of imipramine hydrochloride and placebo. Archives of
General Psychiatry, 40, 125-138.
(145)
GITLIN, B., MARTIN, M., SHEAR, K., FRANCES, A., BALL. G. & JOSEPHSON, S.
(1985) Behavior theraphy for panic disroder. Journal of Nervous and Mental
Diseases, 173, 742-743.
(146)
GORMAN, J.M., PAPP, L. & KLEIN, D.
(1990) Biological Models of Panic Disorder. In Handbook of anxiety, Vol 3(ed.
G.D. Burrows, M. Roth & R. Noyes,Jr.), pp. 59-77. Elsevier Science
Publishers B.V.
(147)
DILLON, D.J., GORMAN, J.M., LIEBOWITZ, M.R., FYER, A.J. & KLEIN, D.F.
(1987) Measurement of lactate-induced panic and anxiety. Psychiatry Research,
20, 97-105.
(148)
PITTS, F.N., ALLEN, R.E. (1979) In Biochemical Induction of Anxiety (eds. Fann,
Karacan, Pokorny & Williams). SP Medical & Scientific Books. New York.
(149)
FYER, A.J., GORMAN, J.M., LIEBOWITZ, M.R., LEVITT, M., DANIELSON, E., MARTINEZ,
J., & KLEIN, D.F.(1984) Sodium lactate infusion, panic attacks, and ionized
calcium. Biological Psychiatry, 19, 1437.
(150)
LIEBOWITZ,M.R., GORMAN, J.M., FYER,A., DILLON,D., LEVITT,M., KLEIN,D.F. (1986)
Possible mechanisms for lactate's induction of panic. American Journal of
Psychiatry, 143, 495‑502.
(151)
GORMAN, J.M., LEVY, G.F., LIEBOWITZ, M.R., MCGRATH, P., APPLEBY, I., DILLON,
D., DAVIES, S.O., KLEIN, D.F.(1983). Intravenous propranolol during sodium
lactate infusion. Psychofarmology Bulletin, 19, 577-578.
(152)
NESSE, R.M., CAMERON, O.G., CURTIS, G.C., MCCANN, D.S. & HABER-SMITH,
M.J.(1984) Adrenergic function in
patients with panic anxiety. Archives of General Psychiatry, 41, 771-776.
(153)
RAINEY, J.M. Jr., POHL, R.B., WILLIAMS, M., et al.(1984). A comparison of
lactate and isoproterenol anxiety states. Psychopathology, 17, 74-82.
(154)
GROSTZ, J.H. & FARMER, B.B. 1972. Pitts' and McClure's lactate anxiety
revisited. British Journal of Psychiatry, 120, 415-418.
(155)
GORMAN, J.M., BATTISTA, D., GOETZ, R.R., DILLON, D.J., LIEBOWITZ, M.R., FYER,
A.J., KAHN, J.P., SANDBERG, D. & KLEIN, D.F. (1990) A comparison of sodium
bicarbonate and sodium lactate infusion in the induction of panics attacks.
Archives of General Psychiatry, 46, 145‑150.
(156)
GORMAN, J.M., FYER, M.R., GOETZ, R., ASKANAZI, J., MARTINEZ, J., LIEBOWITZ,
M.R., FYER, A.J., KINNEY, J. & KLEIN, D.F. (1988) Ventilatory challenge
studies of patients with panic disorder. Archives of General Psychiatry, 45,
31-39.
(157)
WOODS, S.W., CHARNEY, D.S., LOKE, J., GOODMAN, W.K. REDMOND, D.E. Jr &
HENINGER, G.R. (1986) Carbon diaxide sensitivity in panic anxiety. Ventilatory
and anxiogenic response to carbon dioxide in healthy subjects and patients with
panic anxiety before and after alprazolam treatment. Archives of General
Psychiatry, 43, 900-909.
(158)
SALKOVSKIS, P.M., JONES, D.R. & CLARK, D.M. (1986) Respiratory control in
the treatment of panic attacks: Replication and extension with concurrent
measurement of behaviour and pCO2. British Journal of Psychiatry,
148, 526.
(159)
GRIEZ, E.J., LOUSBERG, H., VAN‑DEN‑HOUT, M.A., VAN‑DER‑MOLEN,
G.M.(1987) CO2 vulnerability in panic disorder. Psychiatry Research, 20, 87‑95.
(160)
FYER, M.R., UY, J., MARTINEZ, J., GOETZ, R., KLEIN, D.F., FYER, A., LIEBOWITZ,
M.R. & GORMAN, J. (1987) CO2 challenge of patients with panic
disorder. American Journal of Psychiatry, 144, 1080‑1082.
(161)
WOODS, S.W., CHARNEY, D.S., GOODMAN, W.K. & HENINGER, G.R. (1988) Carbon
dioxide-induced anxiety. Archives of General Psychiatry, 45, 43-52.
(162)
GORMAN, J.M., GOETZ, R.R., UY, J. et al. (1988) . Hyperventilation occurs
during lactate induced panic. Journal of Anxiety Disorder, 2, 193-202.
(163)
SANDERSON, W.C. & WELTZER, S. (1990) Five Percent Carbon Dioxide Challenge:
Valid Analogue and Marker of Panic Disorder?. Biological Psychiatry, 27,
689-701.
(164)
CARR, D.B., FISHMAN, S.M., SYSTROM, D., BECKETT, A., SHEEHAN, D.V. &
ROSENBAUM, J.F. (1987) Carbon dioxide in panic disorder and premenstrually
normals. Proc. Annual Meeting of the Amer. Psychiatric Assoc., Chicago, IL.
(165)
LOUSBERG, H, GRIEZ, E, VAN DEN HOUT, M., VAN‑DER‑MOLEN, M. &
VROEMEN, J. (1990). Carbon dioxide chemosensitivity in panic disorder.
Psychiatrische Praxis, 17, 29‑33.
(166)
GORMAN, J.M. & PAPP, L.A. (1990) Respiratory physiology of panic disorder.
In: J. Ballenger (Ed.), Alan R. Liss, New York, 1990.
(167)
CHARNEY, D.S., HENINGER, G.R., BREIER, A. (1984). Noradrenergic function in
panic anxiety: effects of yohimbine in healthy subjects and patients with
agoraphobia and panic disorder. Archives of General Psychiatry, 41, 751-763.
(168)
MIGNOT, E., LAUDE, D., ELGHOZI, J. et al. (1982) Central administration of yohimbine
increases free 3-methoxy-4-hydroxyphenyl glycol in cerebrospinal fluid of the
rat. European Journal of Pharmacology, 83, 135-138.
(169)
CHARNEY, D.S., HENINGER, G.R. (1986) Abnormal regulation of noradrenergic
function in panic disorders. Effects of clonidine on patients with agoraphobia
and panic disorder. Archives of General Psychiatry, 43, 1042-1054.
(170)
NUTT, D.J. (1986) Increased central alpha2-adrenoreceptor sensitivity in panic
disorder. Psychopharmacol Bulletin, 90, 268-269.
(171) PYKE,
R.E. & GREENBERG, H.S. (1986) Norepinephrine challenges in panic patients.
Journal of Clinica Psychopharmacoly, 6, 279-285.
(172)
CHARNEY, D.S., HENINGER, G.R. & JATLOW, P.I. (1985) Increased anxiogenic
effects of caffeine in panic disorders. Archives of General Psychiatry, 42,
233-243.
(173)
NUTT, D.J., GLUE, P., LAWSON, C. & WILSON, S. (1990) Flumazenil provocation
of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in
panic disorder. Archives of General Psychiatry, 47, 917‑925.
(174)
ACKERMAN, W.E., PHERO, J.C., JUNEJA, M.M. (1989) Panic Disorder Following
2-Chloroprocaine. American Journal of Psychiatry, 46, 940-941.
(175)
BRADWEJN, J., KOSZYCKI, D. & METERISSIAN, G. (1990) Cholecystokinin‑tetrapeptide
induces panic attacks in patients with panic disorder. Canadian Journal of
Psychiatry, 35, 83‑85.
(176)
BRADWEJN, J., KOSZYCKI, D. & SHRIQUI, C. (1991) Enhanced sensitivity to
cholecystokinin-tetrapeptide in panic disorder. Archives of General Psychiatry,
48, 603-610.
(177)
COUETOUX DUTERTRE, A,. BRADWEJN, J., KOSZYCKI, D., PARADIS, M. & BOURIN
M.(1992) Flumazenil does nort antagonize CCK-4 induced panic in healthy
volunteers. En Prensa.
(178)
BRADWEJN, J., KOSZYCKI, D., COUETOUX DUTERTRE, A., VAN MEGEN, H. DEN BOER J, WESTENBERG
H, KARKANIAS, C & HAIGH J. (1992) L- 365, 260, A CCKb receptor antagonist,
blocks CCK-4-panic in panic disorder). En prensa.
(179)
KAHN, R.S., VAN PRAAG, H.M., ASNIS, G.M., et al. (1987) 5-HT receptor
hypersensitivity and anxiety. Presented at 140th Annual Meeting Amer.
Psychiatric Assoc., Chicago, May 1987.
(180)
CHARNEY, D.S., WOODS, S.W., GOODMAN, W.K. & HENINGER, G.R. (1987) Serotonin
function in anxiety. II. Effects of the serotonin agonist MCPP in panic
disorder patients and healthy controls. Psychopharmacology, 92, 14-24.
(181)
DOROW, R., DUKA, T.L., HOLLER, L. & SAUERBREY, N. (1987) Clinical
perspective of betacarbolines from first studies in humans. Brain Research
Bulletin, 19, 319-326.
(182)
SCHACTER, S. & SINGER, J.E. (1969) Cognitive, social and physiological
determinants of emotional state. Psychological Review, 69, 379-399.
(183)
SCHWEITER, E. WINOKUR, A. & RICKELS, K. (1986) Insulin induced hypoglycemia
and panic attacks. American Journal of Psychiatry, 143, 646-655.
(184) ROY-BYRNE,
P., UHDE, T.W., POST, R.M., KING, A.C., BUCHSBAUM, M.S. (1985) Normal pain
sensitivity in patients with panic disorder. Psychiatry Research, 14, 75-82.
(185)
MATHEW, R.J., WILSON, W.H. & TANT, S. (1989) Responses to Hypercarbia
Induced by Acetazolamide in Panic Disorder Patients. American Journal of
Psychiatry, 146, 996-1000.
(186)
Westphal, C. (1892) Gesammelle Abhandlungen, ed A. Westphal (Berlín), 2:557.
Citado en: LEVIN K.(1978) Freud's Early Psychology of the Neuroses. A
Historical Perspective.University of Pittsburgh Press, Pittsburgh (traducido al
castellano en 1985 por el Fondo de cultura económica).
(187)
MATHEW, R.J., & WILSON, W. (1990) Anxiety and Cerebral Blood FLow. American
Journal of Psychiatry, 147, 838-849.
(188)
FONTAINE‑R; BRETON‑G; DERY‑R; FONTAINE‑S; ELIE‑R
(1990)
Temporal lobe abnormalities in panic disorder: an MRI study. Biological
Psychiatry, 27, 304‑310.
(189)
GLOOR, P., OLIVIER, A., QUESNEY, L.F., ANDERMANN, F., HOROWITZ, S.(1982) The
role of the limbic system in experimental phenomena of temporal lobe epilepsy.
Annals of Neurology, 12, 129.
(190)
SCHWARTZ, W.J., SMITH, C.B., DAVIDSEN, L., SAVAKI, H., SOKOLOFF, L., MATA, M.,
FINK, D.J. & GAINER, H. (1979) Metabolic mapping of functional activity in
the hypothalamo‑neurohypophysial system of the rat. Science, 205,
723-725.
(191)
REIMAN, E.M., RAICHLE, M.E., BUTLER, F.K., HERSCOVITCH, P. & ROBINS, E.
(1984) A focal brain abnormality in panic disorder, a severe form of anxiety.
Nature, 310, 683‑685.
(192)
TAYLOR, C.B., KING, R.J., EHLERS, A., MARGRAF, J., CLARK, D., ROTH, W.T. &
AGRAS, W.S. (1990) Treadmill exercise test and ambulatory measures in patients
with panic attacks. American Journal of Cardiology, 60, 487.
(193)
MARGRAF, J., TAYLOR, C.B., EHLERS, A., ROTH, W.T. & AGRAS, W.S. (1987)
Panic attacks in the natural environment. Journal of Nervous and Mental
Disease, 175, 558.
(194)
UHDE, T.W., ROY-BYRNE, P.P., GILLIN, J.C., MENDELSON, W.B., BOULENGER J.P.,
VITTONE, B.J. & POST, R.M. (1984) The sleep of patients with panic
disorder: A preliminary report. Psychiatry Research, 12, 251.
(195)
HAURI, P. & FISHER, J. (1986) Persistent psychophysiologic (learned)
insomnia. Sleep, 9, 38.
(196)
DUBE, S., JONES, D.A., BELL, J., DAVIES, A., ROSS, E. & SITARAM, N. (1986)
Interface of panic and depression: Clinical and sleep EEG correlates.
Psychiatry Research, 19, 119.
(197)
GRUNHAUS, L., RABIT, D., HAREL, Y., GREDEN, J.F., FEINBERG, M. & HERMANN,
R. (1986) Simultaneous panic and depressive disorders: Clinical and sleep EEG
correlates. Psychiatry Research, 17, 251.
(198)
AVERY, D.H., OSGOOD, T.B., ISHIKI, D.M., WILSON, L.G., KENNY, M. & DUNNER,
D.L. (1985) The DST in psychiatric
outpatients with generalized anxiety disorder, panic disorder or primary
affective disorder. American Journal of Psychiatry, 142, 844-847.
(199)
GUILLEMIN, R., VARGO, T., ROSSIER, J. et al. (1984) Beta-endorphin and
adrenocorticotropin are secreted concomitantly by the pituitary gland. Science,
197, 1367.
(200)
MAINES, R., EIPPER, E. & LING, N. (1986) Common precursors to corticotropin
and endorphin . Proceedings of the National Academy of Sciences of the U.S.A.,
74, 3014.
(201)
ROSENBAUM, A.H., WELLS, L.A., SCHATZBERG, A.F., JIANG, N.S., JOST, F.A. III,
MARUTA, T. & CROSS, P.D. (1983) Urinary free cortisol levels in anxiety.
Psychsomatics 24, 835-837.
(202)
KATHOL, R.G., ANTON, R., NOYES, R., LOPEZ, A.L. & REICH, J.H. (1988)
Relationship of urinary free cortisol levels in patients with panic disorder to
symptoms of depression and agoraphobia. Psychiatry Research 24, 211-221.
(203)
KATHOL, R.G., ANTON, R., NOYES, R., & GEHRIS, T. (1989) Direct Comparison
of Urinary Free Cortisol Excretion in patients with Depression and Panic
Disorder. Biological Psychiatry, 25, 873-878.
(204)
CARROLL, B.J. (1985) Dexamethasone suppresion test: a review of contemporary
confusion. Journal of Clinical Psychiatry 46, 13-24.
(205)
MILLN, P., BIDHOP, M. & COPPEN, A. (1981) Urinary free cortisol and
clinical classification of depressive illness. Psychological Medicine, 1,
643-645.
(206)
ROSEMBAUM, A.H., MARUTA, T., SCHATZBERG, A.F., ORSULAK, P.J., JIANG, N.S.,
COLE, J.O. & SCHILDKRAUT, J.J. (1983) Toward a biochemical classification
of depressive disorders, VII: Urinary free cortisol and urinary MHPG in
depressions. American Journal of Psychiatry, 140, 314-317.
(207)
STOKES, P.E., STOLL, P.M., KOSLOW, S.H., MASS, J.W., DAVIS, J.M., SWANN, A.C.
& ROBINS, E. (1984) Pretreatment DST and hypothalamic pituitary
adrenocortical function in depressed patients and comparison groups. Archives
of General Psychiatry, 41, 257-267.
(208)
UHDE, T.W., ROY-BYRNE, P.P., VITTONE, B.J., BOULENGER, J.P. & POST, R.M.
(1985) Phenomenology and neurobiology of panic disorder. In Anxiety and the
Anxiety Disorders (eds A.H. Tuma & J.R. Maser ). Hillsdale NJ: Lawrence
Erlbaum, pp. 557-576.
(209)
CORYELL, W., NOYES, R., & HOUSE, J.D.(1986) Mortality among out-patients
with anxiety disorders. American Journal of Psychiatry, 143, 508-510.
(210)
CURTIS, G.C., CAMERON, O.G., NESSE, R.M. (1982) The dexametasone suppression
test in panic disorder and agoraphobia. American Journal of Psychiatry, 139,
1043-1046.
(211)
KOPP, M.S., ARATO, M., MAGYAR, I. & BUZA, K. (1989) Basal adrenocortical
activity and DST in electrodermally differentiated subgroups of panic patients.
Int J Psychophysiol, 7, 77‑83.
(212)
ROY-BYRNE, P.M., UHDE, T.W., RUBINOW, D.R., & POST, R.M. (1986) Reduced TSH
and prolactin responses to TRH in patients with panic disorder. American
Journal of Psychiatry, 143, 503-507.
(213)
GILLETE, G.M., GARBUTT, J.C., & PRANGE, A.J. (1990) Anxiety and the thyroid
axis. In Handbook of Anxiety, vol 3. The neurobiology of anxiety, vol 3.(eds
Burrows G.D., Roth S.M. & Noyes R. Jr.), pp 365-380. Elsevier Science
Publishers B.V.
(214)
GERACIOTI, T.D., KALOGERAS, K.T., PIGOTT, T.A., DEMITRACK, M.A., ALTEMUS, M.,
CHROUSOS, G.P. & GOLD, P.W. (1990) Anxiety and the
hypothalamic-pituitary-adrenal axis. In Handbook of Anxiety, vol 3. The
neurobiology of anxiety, vol 3. (eds Burrows G.D., Roth S.M. & Noyes R. Jr.),
pp 355-364. Elsevier Science Publishers B.V.
(215)
ROY-BYRNE, P.P., UHDE, T.W., POST, R.M., GALLUCI, W., CHROUSOS, G. & GOLD,
P.(1986) The corticotropin-releasing hormone stimulation test in patients with
panic disorders. American Journal of Psychiatry, 143, 896-899.
(216)
CALOGERO, A.E., GALLUCI, W., CHROUSOS, G.P., GOLD, P.W. (1988) Interaction
between Gabaergic neurotransmission and rat hypothalamic
corticotropin-releasing hormone secretion in vitro. Brain Research, 463, 8.
(217)
BROWN, M.R., FISHER, L.A., SPIESS, J, et al. (1982) Corticotropin releasing
factor: actions on the sympathetic nervous system and metabolism.
Endocrinology, 11, 928.
(218)
SUTTON, R.E., KOOB, G.F., LE MOAL, M., RIVIER, J. & VALE, W. (1982) Corticotropin releasing factor produces
behavioral activation in rats. Nature, 297, 331-333.
(219)
BECK, A. (1974) Ideational components of anxiety neurosis. Archives of General
Psychiatry 31, 319-325.
(220)
MCINTYRE, I.M., JUDD, F.K., MARRIOTT, P.M., BURROWS, G.D. & NORMAN, T.R. (1989)
Plasma melatonin levels in Affective states. International Journal of Clinical
Pharmacology research, 9, 159-164.
(221)
GORMAN, J.M., LIEBOWITZ, M.R., KLEIN, D.F. (1984) Panic disorder and
agoraphobia. Upjohn, Kalamazoo.
(222)
HORNEY, K. (1937) The Neurotic Personality of Our Time (Traducido al castellano
por Editorial Paidós 1985)
(223)
FREUD, S. (1900). La Interpretación de los sueños. En Obras Completas, t.I.
Amorrortu editores.
(224)
FREUD, S. (1926) Inhibitions, symptoms and anxiety. In: Complete Psychological
Works, vol 9 (trans. J.Strachey, 1959), pp. 75-174. LONDON: Hogarth Press.
(225)
CLARK, D.M. (1986) A cognitive approach to panic. Behaviour Research and
Therapy, 24, 461-470.
(226)
HIBBERT, G. (1984) Ideational components of anxiety. Their origin and contents.
British Journal of Psychiatry, 144, 618-624.
(227)
COHEN, M.E., BADAL, D.W., KILPATRICK, A., REED, E.W. & WHITE, P.D. (1951).
The high familial prevalence of neurocirculatory asthenia(anxiety neurosis,
effort syndrome). American Journal of Human Genetics, 3, 126-158.
(228)
NOYES, R. Jr., CLANCY, J., CROWE, R., et al (1978) The familial prevalence of
anxiety neurosis. Archives of General Psychiatry, 35, 1057-1074.
(229)
CROWE, R.R., NOYES, R., PAULS, D.L., & SLYMEN, D. (1983). A family study of
panic disorder. Archives of General Psychiatry, 40, 1065-1069.
(230)
MARKS,I.M. (1986) Genetics of fear and anxiety disorders. British Journal of
Psychiatry, 149, 406‑418.
(231)
TORGENSEN, S. (1983) Genetic factors in anxiety disorders. Archives of General
Psychiatry, 40, 1085-1089.
(232)
TORGENSEN, S. (1986) Childhood and family characteristics in panic and
generalized anxiety disorders. American Journal of Psychiatry, 143, 630-632.
(233)
HOPPER, J.L., JUDD, F.K., DERRICK, P.L., & BURROWS, G.D. (1987) A family
study of panic disorder. Genetic Epidemiology, 4, 33-41.
(234)
NOYES, R., Jr., CROWE, R.R., HARRIS, E.L., HAMRA, B.J., MCCHESNEY, C.M., &
CHAUDHRY, D.R. (1986) Relationship between panic disorder and agoraphobia.
Archives of General Psychiatry, 43, 227-232.
(235)
CROWE, R.R., NOYES, R., WILSON, A.F., ELSTON, R.C. & WARD, L.J. (1987) A
linkage study of panic disorder. Archives of General Psychiatry, 44, 933-937.
(236)
CROWE, R.R., NOYES, R., SAMUELSON, S., WESNER, R. & WILSON, R. (1990) Close
Linkage between Panic Disorder and alfa-haptoglobin excluded in 10 families.
Archives of General Psychiatry, 47, 377-380.
(237)
HARRIS, E.L., NOYES, R., CROWE, R. & CHAUDHRY, D. (1983) Family study of
agoraphobia: report of a pilot study. Archives of General Psychiatry, 40,
1061-1064.
(238)
BALON, R., YERAGANI, V.K. & POHL, R. (1989) Higher Frecuency of Separation
Anxiety in Panic Disorder Patients. American Journal of Psychiatry, 146, 1351.
(239)
CROWE, R.R., NOYES, R. Jr., PERSICO, A.M. (1987) Pro-opiomelanocortin (POMC)
gene excluded as a cause of panic disorder in a large family. Journal of
Affective Disorders, 12, 23-27.
(240)
KLEIN, D.F. (1964) Delineation of two drug-responsive anxiety syndromes.
Psychopharmacologia, 5, 397-408.
(241)
RASKIN, M., PEEKE, H.V., DICKMAN, W. & PINSKER, H. (1982) Panic and
generalized anxiety disorders. developmental antecedents and precipitants.
Archives of General Psychiatry, 39, 687-689.
(242)
GITTELMAN, R. & KLEIN, D.F. (1985) CHildhood separation anxiety and adult
agoraphobia. In Anxiety and the Anxiety Disorders (eds A.H. Tuma & J.R.
Maser ). Hillsdale NJ: Lawrence Erlbaum.
(243)
ARONSON, T.A. & LOGUE, C.M. (1987) On the longitudinal course of panic
disorder. developmental history and predictors of phobic complications.
Comprehensive Psychiatry, 28, 344-345.
(244)
GITTELMAN, R. & KLEIN, D.F. (1984) Relationship between separation anxiety
and panic and agoraphobic disorders. Psychopathology, 17 (suppl 1), 56-65.
(245)
THYER, B.A., HIMLE, J., CURTIS, G.C., CAMERON, O.G. & NESSE, R.M. (1985) A
comparison of panic disorder and agoraphobia with panic attacks. Comprehensive
Psychiatry, 26, 208-214.
(246)
BARLOW, D.H. (1988) En Anxiety and its disorders. New York, Guildford.
(247)
McDANIEL, W.W. (1988) Panic Disorder and Exercise. American Journal of
Psychiatry, 145, 269.
(248)
BARLOW, D. (1988) Current models of panic disorder and a view from emotion
theory. En Review of Psychiatry ( eds. A.Frances & R.Hales), vol 7. APP,
Washington.
(249)
ROTH, M., GURNEY, C., GHARSIDE, R.F. & KERR, T.A. (1972) Studies in the
classification of affective disorders: the relationship between anxiety states
and depressive illnesses. I. British Journal of Psychiatry 121, 147-161.
(250)
TYRER, P.S. (1982) Estados de ansiedad. En Psicopatología de los trastornos
afectivos (coor. Paykel, E.S.), pp, 106-121. Ediciones Pirámide. Madrid.
(251)
NEENAN, P., FELKNER, J. & REICH, J. (1986) Schizoid personality traits
developing secondary to panic disorder. Journal of Nervous and Mental Disease,
174, 483.
(252)
BARLOW, D.H. (1988) Diagnosis and Assessment of Panic Disorder and Agoraphobia.
In Anxiety and its Disorders. The nature and Treatment of Anxiety and Panic,
pp. 356-404. The Guilford Press.
(253)
MAVISSAKALIAN, M. & HAMANN, M.S. (1988) Correlates of DSM-III Personality
Disorder in Panic Disorder and Agorafobia. Comprehensive Psychiatry, 29,
535-544.
(254)
MEZZICH, J.E. (1988) International Classification in Psychiatry (ed. J.E.
Mezzich & M.V. Cranach).
(255)
ROBINS, L.N., HELZER, J.E., WEISSMAN, M.M., ORVASCHEL, H., GRUENBERG, E.,
BURKE, J.D. & REGIER, D.A. (1984) Life-time prevalence of specific
psychiatric disorders at three sites. Archives of General Psychiatry, 41,
949-958.
(256)
MYERS, J.K., WEISSMAN, M.M., TISCHLER, G.L., HOLZER, C.E., LEAF, P.J.,
ORVASCHEL, H., ANTHONY, J.C., BOYD, J.H., BURKE, J.D. Jr., KRAMER, M., &
col. (1984) Six‑month prevalence
of psychiatric disorders in three communities 1980 to 1982. Archives of General
Psychiatry, 41, 959-967.
(257) NORTON,
G.R., HARRISON, B., HAUCH, J. & RHODES, L. (1985) Characteristics of people
with infrecuent panic attacks. J Abnorm Psychol, 94, 216-221.
(258)
MARKOWITZ, J.S., WEISSMAN, M.M., OUELLETTE, R., LISH, J.D. & KLERMAN, G.L.
(1989) Quality of life in panic disorder. Archives of General Psychiatry, 46,
984‑992.
(259)
WARE, J.E. Jr., BROOK, R.H., DAVIES, A.R. & LOHR, K.N. (1981) Choosing
measures of health status for individuals in general populations. American
Journal of Public Health, 71, 620-625.
(260)
JOHNSON, J., WEISSMAN, M.M. & KLERMAN, G.L. (1990) Panic disorder,
comorbidity, and suicide attempts.
Archives of General Psychiatry, 47, 805‑808.
(261)
MUNJACK, D.J., MOSS, H.B. (1981) Affective disorder and alcoholism in families
of agoraphobics. Archives of General Psychiatry, 38, 869-871.
(262)
CORYELL, W., NOYES, R., CLANCY, J. (1982) Excess mortality in panic disorders.
Archives of General Psychiatry, 39, 701-703.
(263)
WEISSMAN, M.M., KLERMAN, G.L., MARKOWITZ, J.S. & OUELLETTE, R. (1989) Suicidal
ideation and suicide attempts in panic disorder and attacks. New England
Journal of Medicine, 321, 1209‑1214.
(264)
WOODS, S.W., CHARNEY, D.S., MCPHERSON, C.A., GRADMAN, A.H. & HENINGER, G.R.
(1987) Situational panic attacks. Archives of General Psychiatry, 44, 365-375.
(265)
KAHN, J. P., GORMAN, J. M., KING, D. L., FYER, A. J., LIEBOWITZ, M. R. &
KLEIN, D. F. (1990) Cardiac left ventricular hypertrophy and chamber dilatation
in panic disorder patients: implications for idiopathic dilated cardiomyopathy.
Psychiatry Research, 32, 55‑61.
(266)
HAYWARD, C. D., TAYLOR, B., ROTH, W. T., KING, R. & AGRAS,S. (1989) Plasma
lipid levels in patients with panic disorder or agoraphobia. American Journal
of Psychiatry, 146, 917-919.
(267)
VENKATESH, A., PAULS, D.L., CROWE, R., NOYES, R. Jr., VAN‑VALKENBURG, C.,
MARTINS, J.B. & KERBER, R.E. (1980) Mitral valve prolapse in anxiety
neurosis (panic disorder). American Heart Journal, 100, 302‑305.
(268)
SHEAR, M.K., DEVEREUX, R.B., KRAMER-FOX, R., MANN, J.J. & FRANCES, A.
(1984) Low prevalence of mitral valve prolapse in patients with panic disorder.
American Journal of Psychiatry, 141, 302‑303.
(269)
GRUNHAUS, L., GLOGER, S. & BIRMACHER, B. (1984) Clomipramine treatment for
panic attacks in patients with mitral valve prolapse. Journal of CLinical
Psychiatry, 45, 25‑27.
(270)
CROWE, R.R., PAULUS, D.L., KERBER, R.E. & col. (1981) Panic disorder and
mitral valve prolapse. En Anxiety: New research and changing concepts (eds.
D.E. Klein & J. Rankin). pp. 103-116. New York: Raven Press.
(271)
MATUZAS, W., AL‑SADIR, J., UHLENHUTH, E.H., GLASS, R.M. & EASTON, C.
(1989) Correlates of mitral valve prolapse among patients with panic
disorder.Psychiatry Research, 28, 161‑170.
(272)
COHEN, L.S., ROSENBAUM, J.F. & HELLER, V.L. (1989) Panic Attack-Associated
Placental Abruption: A Case Report. Journal of Clinical Psychiatry, 50,
266-267.
(273)
HYLER, S.E. & FRANCES, A.(1985) Clinical implications of Axis I‑Axis
II interactions. Comprehensive Psychiatry, 26, 345‑351.
(274) GREER,
S. & CRAWLEY, R.H. (1966) Some Observations on the Natural History of
Neurotic Illness. Archdall Medical Monograph No.3. Sydney, Australia:
Australian Medical Publishing Co.
(275)
NOYES, R., GARVEY, M.J. & COOK, B.L. (1989) Follow-up study of patients
with panic disorder and agoraphobia with panic attacks treated with tricyclic
antidepressants. Journal of Affective Disorders, 16, 249-257.
(276)
WHEELER, E.O., WHITE, P.D., REED, E.W. & COHEN, M.E. (1950).
Neurocirculation asthenia(anxiety neurosis effort syndrome, neurasthenia): a
twenty-year follow-up study of one hundred and seventy-three patients. Journal
American Medical Assistance, 142, 878-888.
(277)
MILES, H.H.W., BANABEC, E.L. & FINESINGER, J.E. (1951) Evaluation of
psychotherapy with a follow-up of 62 cases with anxiety neurosis. Psychosomatic
Medicine, 13, 83-105.
(278)
EITINGER, L. (1955) Studies in neuroses. Acta Pychiatrica Scandinavica
supplementum 101, 5-47.
(279)
ERNST, K. (1959) Die Prognose der Neurosea. Monograph on Neurology and
Psychiatry, 85. New York, NY: Springer- Verlag NY Inc.
(280)
SCHAPIRA, K., ROTH, M., KERR, T.A. & GURNEY, C. (1972) The prognosis of
affective disorders: the differentiation of anxiety states from depressive
illnesses. British Journal of Psychiatry, 121, 175-181.
(281)
NOYES, R. Jr., CLANCY, J., HOENK, P.R. & SLYMEN, D.J. (1980) The prognosis
of anxiety neurosis. Archives of General Psychiatry, 37, 173-178.
(282)
WITTCHEN, H.U. & VON‑ZERSSEN, D. (1988) The course of treated and
untreated depressions and anxiety disorders. A clinico‑psychiatric and
epidemiological follow‑up study. Monographien Aus Dem Gesamtgebiete der Psychiatrie, Psychiatry series, 50,
421.
(283)
LESSER, I.M., RUBIN, R.T., PECKNOLD, J.C., RIFKIN, A., SWINSON, R.P., LYDIARD,
R.B., BURROWS, G.D., NOYES, R., DUPONT, R.L.(1988) Secondary depression in panic disorder and agoraphobia, I:
frecuency, severity and response to treatment. Archives of General Psychiatry,
45, 437-443.
(284)
BULLER, R., MAIER, W. & BENKERT, O. (1986) Clinical subtypes in panic
disorder: their descriptive and prospective validity. Journal of Affective
Disorders, 11, 105‑114.
(285)
BREIER, A., CHARNEY, D.S. & HENINGER, G.R. (1984) Mayor depression in
patients with agoraphobia and panic disorder. Archives of General Psychiatry,
41, 1129-1135.
(286)
NUTZINGER, D.O. & ZAPOTOCZKY, H.G. (1985) The influence of depression on
the outcome of cardiac phobia(panic disorder). Psychopathology, 18, 155-162.
(287)
FARAVELLI, C. & ALBANESI, G. (1987) Agoraphobia with panic attacks: 1 year
prospective follow-up. Comprehensive Psychiatry, 28, 481-487.
(288)
REICH, J., NOYES, R. Jr., HIRSCHFELD, R., CORYELL, W. & O'GORMAN, T. (1987)
State and personality in depressed and panic patients. American Journal of Psychiatry, 144, 181‑187.
(289)
MAVISSAKALIAN, M., PEREL, J., BOWLER, K. & DEALY, R. (1987) Trazodone in
the Treatment of Panic Disorder and Agoraphobia with Panic Attacks. American
Journal of Psychiatry, 144, 785-787.
(290)
FRIEDMAN, C.J., SHEAR, M.K. & FRANCES, A. (1987) DSM-III personality
disorders in panic patients. Journal of Personality Disorder, 1, 132-135.
(291)
GREEN, M.A. & CURTIS, G.C. (1988) Personality disorders in panic patients:
response to termination of antipanic medication. Journal of Personality Disorder,
2, 303-314.
(292)
KOENIGSBERG, H.W., KAPLAN, R.D., GILMORE, M.M. & COOPER, A.M. (1985) The
relationship between syndrome and personality disorder in DSM-III: experience
with 2,462 patients. American Journal of Psychiatry, 142, 404-408.
(293)
KATERNDAHL, D.A. (1989) Factors in The Panic- Agoraphobia Transition. The
Journal of the American Board of Family Practice, 2, 10-16.
(294)
MOUNTJOY, C.Q. & ROTH, M. (1982)
Studies in the relationship between depressive disorders and anxiety
states:II. Clinical items. Journal of Affective Disorders, 4, 149-161.
(295)
KERR, T.A., ROTH, M. & SCHAPIRA, K. (1974) Prediction of outcome in anxiety
states and depressive illnesses. British Journal of Psychiatry, 124, 125‑133.
(296)
LECKMAN, J.F., MELIKANSAS, K.R., PAULS, D.L., PRUSUFF, B.A. & WEISSMAN,
M.M. (1983) Anxiety disorders and
depression: contradictions between family study data and DSM-III conventions.
American Journal of Psychiatry, 140, 880-882.
(297)
WEISSMAN, M., LEAF, P.J., HOLZER, C.E. & MERIKANGAS, K.R. (1985) The
epidemiology of anxiety disorder: A higlight of recent evidence.
Psychopharmacology Bulletin, 21, 538-541.
(298)
SHEEHAN, D.V. (1986) Tricyclic antidepressants in the treatment of panic and
anxiety disorders. Psychosomatics, 27 (suppl.), 10-16.
(299)
UHDE, T.W., VITTONE, B.J., SIEVER, L., KAYE, W. & POST, R.M. (1986) Blunted
growth hormone response to clonidine in panic disorder patients. Biological
Psychiatry, 21, 1081-1085.
(300)
CORYELL, W., NOYES, R. Jr. & REICH, J. (1991) The prognostic significance
of HPA‑axis disturbance in panic disorder: a three‑year follow‑up.
Biological Psychiatry, 15, 96‑102.
(301)
ROSENBERG, C.M. (1968) Complications of obsessional neurosis. British Journal
of Psychiatry, 114, 477‑478.
(302)
MELLMAN, T.A. & UHDE, T.W. (1987)
Obsessive-compulsive symptoms in panic disorder. American Journal of
Psychiatry, 144, 1573.
(303)
ZOHAR, J., INSEL, T.R., ZOHAR-KADOUCH, R.C., HILL, J.L. & MURPHY, D.L.
(1988) Serotonergic responsivity in obsessive-compulsive disorder: effects of
chronic clomipramine treatment. Archives of General Psychiatry, 45, 167.
(304)
MURPHY, D.L., PIGOTT, T.A. & INSEL, T.R. (1990) Obsessive-compulsive disorder and anxiety. In Handbook of
Anxiety. The neurobiology of anxiety, vol 3.(eds Burrows G.D., Roth S.M. &
Noyes R. Jr.), pp. 269-287. Elsevier Science Publishers B.V.
(305)
KUSHNER, M.G., SHER, K.J. & BEITMAN, B.D. (1990) The relation between
alcohol problems and anxiety disorders. American Journal of Psychiatry, 147,
685-695.
(306) STARKMAN,
M.N., ZELNIK, T.C., NESSE, R.M. & CAMERON, O.G. (1985) Anxiety in patients
with pheochromocytomas. Archives of
Internal Medicine, 145, 248‑252.
(307)
GORMAN, J.M., FYER, A.F., GLIKLINCH J, et al (1981) Effect of imipramine on prolapse mitral valves of patients with
panic disorder. American Journal of Psychiatry, 138, 977-978.
(308)
HOEHN-SARIC, R. (1983) Anxiety, panic and agoraphobia. Delaware Medical
Journal, 55, 333.
(309)
KLEIN, D. & FINK, M. (1962) Psychiatric reaction patterns to imipramine.
American Journal of Psychiatry, 119, 432-438.
(310)
MODIGH, K. (1987) Antidepressant drugs in anxiety disorders. Acta Psychiatrica
Scandinavica, 76 (suppl. 335), 57-71.
(311)
MARKS, I.M., GRAY, S., COHEN, D., HILL, R., MAWSON, D. RAMM, E. & STERN, R.S. (1983) Imipramine
and brief therapist-aided exposure in agoraphobics having self-exposure
home-work: a controlled trial. Archives of General Psychiatry, 40, 153-162.
(312)
MAVISSAKALIAN, M. (1984) The relationship of plasma imipramine and desmethylimipramine
to improvement on agoraphobia.Journal of Clinical Psychopharmacology, 4, 36-40.
(313)MAVISSAKALIAN,
M.R., TURNER, S.M., MICHELSON, L. & JACOB, R. (1985) Tricyclic
antidepressants in obsessive-compulsive disorder: anti-obsessional or antidepressant
agents?. American Journal of Psychiatry, 142, 572-576.
(314) DEN
BOER, J.A., WESTENBERG, H.G., KAMERBEEK, W.D., VERHOEVEN, W.M. & KAHN,
R.S. (1987) Effect of serotonin uptake
inhibitors in anxiety disorders; a double blind comparison of clomipramine and
fluvoxamine. International Clinical
Psychopharmacology, 2, 21-32.
(315) DEN
BOER, J.A. & WESTENBERG, H.G. (1988) Effect of serotonin and noradrenaline
uptake inhibitor in panic disorder: a double blind comparative study with
fluvoxamine and maprotiline. Int clin Psychopharmacol, 3, 59-74.
(316)
SCHNEIER, F.R., LIEBOWITZ, M.R., DAVIES, S.O., FAIRBANKS, J., HOLLANDER, E.,
CAMPEAS, R. & KLEIN, D.F. (1990) Fluoxetine in panic disorder. Journal of
Clinical Psychopharmacoly, 10, 119‑121.
(317) EVANS,
L., KENARDY, J., SCHNEIDER, P. & HOEY, H. (1986) Effect of a selective
serotonin uptake inhibitor in agoraphobia with panic attacks. A doubleblind
comparison of zimelidine, imipramine and placebo. Acta Psychiatrica
Scandinavica, 73, 49-53.
(318)
MAVISSAKALIAN, M., PEREL, J., BOWLER, K. & DEALY, R. (1987) Trazodone in
the Treatment of Panic Disorder and Agoraphobia with Panic Attacks. American
Journal of Psychiatry, 144, 785-787.
(319)
KAHN, R.S., WESTENBERG, H.G., VERHOEVEN, W.M., GISPEN-DE-WIED, C.C. & KAMERBEEK, W.D. (1987) Effect of a serotonin
precursor and uptake inhibitor in anxiety disorders; a double blind comparison
of 5-hydroxytryptophan, clomipramine and placebo. Int- Clin-Psychopharmacol, 2,
33-45.
(320)
GLOGER, S. GRUNHAUS, L, BIRMACHER, B. & TROUDART, T. (1981) Treatment of
spontaneous panic attacks with clomipramine. American Journal of Psychiatry,
138, 1215-1217.
(321)
SHEEHAN, D., BALLENGER, J. & JACOBSEN, G. (1980) Treatment of endogenous
anxiety with phobic, hysterical and hypocondriacal symptoms. Archives of
General Psychiatry, 37, 51-59.
(322)
MAVISSAKALIAN, M. & PEREL, J. (1985) Imipramine in the Treatment of
Agoraphobia: Dose-Response Relationships. American Journal of Psychiatry, 142,
1032-1036.
(323)
CASSANO, G. & DELTITO, J. (1986) Standard therapies for panic disorder. In
Drug treatment of neurotic disorders (eds. L. M. Davies & H. Linvingstone.
(324)
BRESLOW, M.F., FANKHAUSER, M.P., POTTER, R.L., MEREDITH, K.E., MISIASZEK, J.,
& HOPE, D.G. (1989) Role of gamma- aminobutyric acid in Antipanic Drug
Efficacy. American Journal of Psychiatry, 146, 3.
(325)
GUIDOTTI, A., CORDA, M.G., WISE, B.C., VACCARINO, F. & COSTA, E. (1983)
GABAergic synapses. Supramolecular organization and biochemical regulation.
Neuropharmacology, 22, 1471‑1479.
(326)
ENNA, S.J. (1984) Role of gamma‑aminobutyric acid in anxiety.
Psychopathology, 17, 15‑24.
(327)
PATEL, G.J., SCHATZ, R.P., CONSTANTINIDES, S.M. & LAL, H. (1975) Effect of
desipramine and pargyline on brain gamma‑aminobutyric acid. Biochemical
Pharmacology, 24, 57‑60.
(328)
PILC, A. & LLOYD, K.G. (1984) Chronic antidepressants and GABA
"B" receptors: a GABA hypothesis of antidepressant drug action. Life
Sciences, 35, 2149‑2154.
(329)
RIBLET, L.A., TAYLOR, D.P. & EISON, M.S. (1982)
Pharmacology
and neurochemistry of buspirone. Journal of Clinical Psychiatry, 43, 11‑18.
(330)
JUDD, K.F., NORMAN, T.R. & BURROWS, G.D.
(1986) Pharmacological treatment of panic disorder. International
Clinical Psychopharmacology, 1, 3-16.
(331)
GORMAN, J.M. & GORMAN, L.K. (1987) Drug treatment of social phobia. Journal
of Affective Disorders, 13, 183-192.
(332)
MODIGH, K. & SVENSSON, T.H. (1972) On the role of central nervous system
catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioral
syndrome. Br. J. Pharmacol., 46, 32-45.
(333)
SHEEHAN, D., CLAYCOMB, J. & SURMAN, O. (1984) The relative efficacy of
alprazolam, phenelzine, and imipramine in treating panic attacks and phobias.
Meeting APA. Los Angeles.
(334)
LIEBOWITZ, M.R., GORMAN, J.M., FYER, A., DILLON, D., LEVITT, M. & KLEIN,
D.F. (1986) Possible mechanisms for lactate's induction of panic. American
Journal of Psychiatry, 143, 495‑502
(335)
SHEEHAN, D.V.M.D., ZAK, J.P., MILLER, J.A. & FANOUS, B.S.L. (1988) Panic
Disorder: The Potential Role of Serotonin Reuptake Inhibitors. Journal of
Clinical Psychiatry, 49:8.
(336)
MURPHY, D.L., AULALCH, C.S., GARRICK, N.A. & SUNDERLAND, T. (1987)
Monoamine Oxidase Inhibitors as Antidepressants: Implications for the Mechanism
of Action of Antidepressants and the Psychobiology of the Affective Disorders
and Some Related Disorders. En Psychopharmacology, The Third Generation of
Progress. edited by HY. Meltzer. pp. 545-552. New York: Raven Press.
(337)
TRULSON, M.E., PREUSSLER, D.W., HOWELL, G.A. & FREDERICKSON, C.J. (1982)
Raphe unit activity in freedly moving cats: effects of benzodiacepines.
Neuropharmacology, 21, 1045-1050.
(338)
KLERMAN, G.L. et al. Drug Treatment of Panic Disorder. Reply to Comment by
Marcks I and Associates. British Journal of Psychiatry. En prensa.
(339)
MCNAIR, M.M. & KAHN, R.J. (1981) Imipramine compared with benzodiacepine
for agoraphobia. En Anxiety: New
research and changing concepts (eds. D.E. Klein & J. Rankin). pp. 69-80.
New York: Raven Press.
(340)
NOYES R., ANDERSON, D.J., CLANCY, J., et al (1984) Diazepam and propranolol in
panic disorder and agoraphobia. Archives of General Psychiatry, 41, 287-292.
(341)
CHOUINARD, G., ANNABLE, L., FONTAINE, R. & SOLYOM, L. (1982) Alprazolam in
the treatment of generalized anxiaty and apanic disorders: a double-blind
placebo-controlled study. Psychopharmacology, 77, 229-33.
(342)
SHEEHAN, D.V. (1984): Delineation of anxiety and phobic disorders responsive to
monoamine oxidasa inhibitors: implications for classification. Journal of
Clinical Psychiatry, 45, 29-36.
(343)
BALLENGER, J., RUBIN, R., DUPONT, R. (1985) Treatment of agoraphobia panic
disorder with alprazolam: Preliminary results from a large multicenter
placebo-controlled trial. Annual NCDEU Meeting, Key Biscayne.
(344)
LEPOLA, U., JOLKKONEN, J., RIMON, R. & RIEKKINEN, P. (1989) Long‑term
effects of alprazolam and imipramine on cerebrospinal fluid monoamine
metabolites and neuropeptides in panic disorder. Neuropsychobiology, 21, 182‑186
(345)
GRIEZ, E.J.L., LOUSBERG, H., VAN DEN HOUT, M.A. & VAN DER MOLEN, G. (1987)
CO2 Vulnerability in Panic Disorder Psychiatry Research, 20, 87-95.
(346)
HOES, M.J., COLLA, P. & FOLGERING, H. (1981) Hyperventilation syndrome ,
treatment with L-tryptophan and pyridoxine; predictive values of xanthurenic
acid excretion. Journal of Orthomolecular Psychiatry, 10, 7-15.
(347)
PRIMEAU, F, FONTAINE, R. & BEAUCLAIR, L. (1990) Valproic acid and panic
disorder. Canadian Journal of Psychiatry, 35, 248‑250.
(348)
BRESLOW, M.F., FANKHAUSER, M.P., POTTER, R.L., MEREDITH, K.E., MISIASZEK, J.
& HOPE, D.G. (1989) Role of gamma-aminobutyric acid in Antipanic Drug
Efficacy. American Journal of Psychiatry, 146, 3.
(349) KO,
G., ELSWORTH, J. & ROTH, R. (1987)
Panic and avoidance in agoraphobia, application of path analysis to
treatment studies. Archives of General Psychiatry, 44, 377-385.
(350)
ABELSON, J.L., NESSE, R.M. & VINIK, A. (1990) Treatment of panic‑like
attacks with a long‑acting analogue of somatostatin. Journal of Clinical
Psychopharmacoly, 10, 128‑132.
(351)
CALOGERO, A.E., GALLUCI, W.T., TOMAI, T.P., LORIAUX, D.L., CHROUSOS, G.P. &
GOLD, P.W. (1987) Inhibition of corticotropin releasing hormone secretion by
GABA A and GABA B receptor action in vitro. Clinical implications. En Recent
advances in adrenal regulation and function (eds. R. D'Agata &
G.P.Chrousos) pp. 279-284. New York:Raven Press.
(352)
BEAL, J.F., UHL, G., MAZUREK, M.F., KOWALL, H. & MARTIN, J.B. (1986)
Somatostatin: alterations in the central nervous system in neurological
diseases. En Neuropeptides in neurologic ans psychiatric disease (eds J.B.
Martin & J.D. Barchas JD), pp. 215-257. New York: Raven Press,
(353)
POHL, R., BALON, R., YERAGANI, V.K. & GERSHON, S. (1989) Serotonergic
anxiolytics in the treatment of panic disorder: a controlled study with
buspirone. Psychopathology, 22, 60-67.
(354)
ROBINSON, D.S., SHROTRIYA, R.C., ALMA, D.R., MESSINA, M. & SNDSRY, J.
(1989) Treatment of panic disorder: nonbenzodizepine anxiolytics, including
buspirone. Psychopharmacology Bulletin, 25, 21-26.
(355)
SHEEHAN, D.V., RAJ, A.B., SHEEHAN, K.H. & SOTO, S. (1990) Is buspirone
effective for panic disorder?. Journal of Clinical Psychopharmacoly, 10, 3‑11.
(356)
GORMAN, J.M., LEVY, G.F., LIEBOWITZ, M.R., MCGRATH, P., APPELBY, I.L., DILLON,
D.J., DAVIES, S.O. & KLEIN D.F. (1983) Effect of acute beta-adrenergic
blockade on lactate-induced panic. Archives of General Psychiatry, 40,
1079-1082.
(357)
YERAGANI, V.K., POHL, R. & BALON, R. (1989) Lactate-Induced Panic and
Beta-Adrenergic Blockade. (Letter). Psychiatry Research, 32, 93-94.
(358)
MELLERGARD, M. & ROSENBERG, N.K. (1990) Patterns of response during placebo
treatment of panic disorder.
Acta
Psychiatr Scand, 81, 340‑344.
(359)
SALKOVSKIS, P.M., CLARK, D.M. & HACKMANN, A. (1991) Treatment of panic
attacks using cognitive therapy without exposure or breathing retraining. Behav
Res Ther., 29, 161‑166.
(360)
HEIDE, F.J. & BORKOVEC, T.D. (1983) Relaxation‑induced anxiety:
paradoxical anxiety enhancement due to relaxation training. Journal of
Consulting and Clinical Psychology, 51, 171‑182.
(361)
SPITZER, R.L., ENDICOTT, J., ROBINS, E. (1978) Research Diagnostic
Criteria:Rationale and reliability, Archives of General Psychiatry,
35:773-782,1978. (ed 3). New York State Psychiatric Institute.
(362)
LOPEZ-IBOR ALIÑO, J.J. (1980) El sistema A.M.D.P. (Asociación para la
metodología y Documentación en Psiquiatría). Garsi. Madrid.
(363)
HAMILTON, M. (1959) The assessment of anxiety states by rating. Br. J Med
Psychol 32, 50-55.
(364)
MIGUEL TOBAL, J.J.& CANO VINDEL, A.R.Inventario de situaciones y respuestas
de ansiedad. TEA ediciones.
(365)
EYSENCK, H.J. & EYSENCK, D.B.G. EPI, Cuestionario de personalidad. TEA
ediciones.
(366)
BELL, H.M. Cuestionario de adaptación para adultos. H.M.Bell. Adaptación
española (trad. E.Cerda). TEA ediciones.
(367)
GRÜNBAUM, A, (1986) The placebo concept in medicine andpsychiatry.
Psychological Medicine, 16, 19-38.
(368) VAN
PRAAG, H., LEMUS, C., KAHN, R. (1987)
Hormonal probes of central serotonin activity: do they really exist?.
Biological Psychiatry, 22,86.
(369)
HENINGER, G.R. & CHARNEY, D.S. (1987) Mechanism of Action of Antidepressant
Treatments: Implications for the Etiology and Treatment of Depressive
Disorders. En Psychopharmacology, The Third Generation of Progress. edited by
HY. Meltzer. pp.535-544. New York: Raven Press.
(370)
MORENO, I., SAIZ-RUIZ, J. & LOPEZ-IBOR J.J. (1991) Serotonin and Gambling
dependence. Human psychopharmacology, vol 6, 9-12.
(371)
VAZQUEZ, A.M., ARRANZ, M.I., LOPEZ-IBOR, J.J., GARCIA, M., VIÑAS, R., MORENO,
I. & MORALES, V. (1991) Clomipramine test: serum level determination in
three groups of psychiatric patients. Journal of Pharmaceutical &
Biomedical Analysis, 9, 949-952.
(372)
VIÑAS, R. (1991) Trastorno obsesivo-compulsivo. Estudio clínico y neuroquímico
. Tesis doctoral. Universidad Autónoma de Madrid.
(373)
MORENO OLIVER, I. (1991) Juego Patológico. Estudio clínico y neuroquímico.
Tesis doctoral. Universidad de Alcalá de Henares. Madrid.
(374)
GOLDEN, R.N., HSIAO, J.K., LANE, E., HICKS, R., ROGERS, S. & POTTER, W.Z.
(1989) The effects of intravenous clomipramine on neurohormones in healthy
subjects. Journal of Clinical Endocrinology and Metabolism, 68, 632-637.
(375)
PARDRIDGE, W.M. & OLDENDORF, W.H. (1977) Transport of metabolic substrates
through the blood brain barrier. Journal of Neurochemistry, 28, 5-12.
(376) NASH, J.F. & MELTZER, H.Y.
Neuroendocrine Studies in Psychiatric Disorders. The Role of Serotonin. en The
Role of Serotonin in Psychiatric Disorders (eds. S.L. BROWN & H.M.
VAN-PRAAG), pp, 57-90. Albert Einstein College of Medicine of Yeshiva
University. New York.
(377)
LOPEZ‑IBOR, J.J. Jr., LANA, F., SAIZ‑RUIZ, J. (1990) Impulsive
suicidal behavior and serotonin. Actas Luso Españolas de Neurología,
Psiquiatría y Ciencias afines, 18, 316‑25.
(378)
GOLDSTEIN, S., HALBREICH, U., ASNIS, G. ENDICOTT, J. & ALVIR, J. (1987) The
hypothalamic-pituitary-adrenal system in panic disorder. Biological Psychiatry,
144, 1320-3.
(379)
ROY-BYRNE, P.P., UHDE, T.W., GOLD, P.W., RUBINOW, D.R. & POST, R.M. (1985)
Neuroendocrine abnormalities in panic disorder. Psychopharmacology Bulletin,
21, 546-50.
(380)
MASALA, A., DELITALA, G., DEVILLA, L. ALAGNA, S. & ROVASIO, P.P. (1979)
Enhancement of insulin‑induced prolactin secretion by fluoxetine in man.
Journal of Clinical Endocrinology and Metabolism, 49, 350‑2.
(381) VON‑BARDELEBEN,
U., HOLSBOER, F. (1988) Human corticotropin releasing hormone: clinical studies
in patients with affective disorders, alcoholism, panic disorder and in normal
controls. Progress in Neuropsychopharmacoly and Biological Psychiatry, 12
Suppl, 165‑87.
(382)
LOPEZ, A.L., KATHOL, R.G. & NOYES, R. Jr. (1990) Reduction in urinary free
cortisol during benzodiazepine treatment of panic disorder.
Psychoneuroendocrinology, 15, 23‑8.
(383)
SACHAR, E.J., HELLMAN, L., FUKUSHIMA, D.K. & GALLAGHER, T.F. (1970)
Cortisol production in depressive illness: a clinical and biochemical
classification. Archives of General Psychiatry, 23, 289-98.
(384)
ROY-BYRNE, P.P., UHDE, T.W., SACK, D.A., LINNOILA, M. & POST, R.M. (1986)
Plasma HVA and anxiety in patients with panic disorder. Biological Psychiatry,
21, 849.
(385)
TIETZ, N.W. (1983) Intervalos de referencia y valores de laboratorio de importancia
clínica. En Tratado de Medicina Interna de Cecil, 16ª edición (eds. J.B.
Wyngaarden & LL.H. Smith).Interamericana.
(386)
CHARNEY, D.S., HENINGER, G.R. (1986) Serotonin function in panic disorders. The
effect of intravenous tryptophan in healthy subjects and patients with panic
disorders before and during alprazolam treatment. Archives of General
Psychiatry, 43, 1059.
(387)
GOLDEN, R.N., HSIAO, J.K., LANE, E., EKSTROM, D., ROGERS, S., HICKS, R. &
POTTER, W.Z. (1990) Abnormal Neuroendocrine Responsivity to Acute I.V.
Clomipramine Challenge in Depressed Patients. Psychiatry Research, 31, 39-47.
(388)
CHECKLEY, S. & ARENDT, J. (1984) Pharmacoendocrine Studies of GH, PRL, and
Melatonin in Patients with Affective Illness. En Neuroendocrinology and Psychiatric
Disorder (ed. G.M.Brown). Raven Press, New York.
(389)
DANIELS, G.H. & MARTIN, J.B. (1989) Regulación neuroendocrina y
enfermedades de hipófisis anterior e hipotálamo. En Harrison: Principios de
Medicina Interna, 11ª edición (7ªedición en español), pp. 2073-2100 (eds. E.
Braunwald, K.J.Isselbacher, R.G.Petersdorf, J.D. Wilson, J.B. Martin &
A.S.Fauci). Interamericana, McGraw-Hill.
(390)
MURPHY, D.L., ZOHAR, J., BENKELFAT, C., PATO, M.T., PIGOTT, T.A. & INSEL,
T.R. (1989) Obsessive-compulsive isorder as a 5-Ht subsystem-related
behavioural disorder. British Journal of Psychiatry supplementum, 8, 15-24.
(391)
GLASS, A.R., SMALLRIDGE, R.C., SCHAAF, M. & DIMOND, R.C. (1980) Absent
prolactin response to L‑tryptophan in normal and acromegalic
subjects. Psychoneuroendocrinology, 5,
261-265.
(392)
HYYPPA, M.T., JOLMA, T., LIIRA, J. LANGVIK, V.A. & KYTOMAKI, O. (1979) L‑tryptophan
treatment and the episodic secretion of pituitary hormones and cortisol. Psychoneuroendocrinology 4: 29-35.
(393)
WETTERBERG, L. & ERIKSSON, O. (1981) Melatonin: Current Status and
Perspectives. (eds. N. Birau & W. Schloot), pp, 15-20. Pergamon Press,
Oxford.
(394)
CHRISTY, N.P. (1983) Hipófisis anterior. En Tratado de Medicina Interna de
Cecil, 16ª edición (eds. J.B. Wyngaarden & LL.H. Smith).Interamericana.
(395)
LAAKMAN, G., GUGATH, M., KUSS, H.J. & ZYGAN, K. (1984) Comparison of growth
hormone and prolactin stimulation induced by chlomipramine and desipramine in
man in connection with chlorimipramine metabolism. Psychopharmacology, 82,
62-67.
(396) LAL,
S., NAIR, N.P. & GUYDA, H. (1978) Effect of lithium on hypothalamic‑pituitary
dopaminergic function. Acta Psychiatrica Scandinavica, 57, 91‑96.
(397)
HALBREICH, U., SACHAR, E.J., NATHAN, R.S., ASNIS, G.M. & HALPERN, F.S. (1980)
The effect of benztropine mesylate on the prolactin response to haloperidol.
Psychopharmacology, 72, 61‑5.
(398)
Curtis GC. 1979: In: Mind and Coucer Prognosis, edited by BA Stall, pp 61-73.
John Wiley and Sons Ltd.).
(399) DEMAREST, K.T., MOORE, K.E. & RIEGLE,
G.D. (1985) Acute restraint stress decreases dopamine synthesis and turnover in
the median eminence: a model for the study of the inhibitory neuronal
influences on tuberoinfundibular dopaminergic neurons. Neuroendocrinology, 41,
437-444.
(400)
DEMAREST, K.T., MOORE, K.E. & RIEGLE, G.D. (1985) Acute restraint stress
decreases tuberoinfundibular dopaminergic neuronal activity: evidence for a
differential response in male versus female rats. Neuroendocrinology, 41,
504-510.
(401)
COLE, E.N., GROOM, G.U., LINK, J. OÇFLANAGAN, P.M. & ELDRUP, J. (1976) Plasma
prolactin concentrations in patients on clomipramine. Postgrad med, 52
(suppl.3), 93-100.
(402)
PREZIOSI, P. (1983) Serotonin control of prolactin release.: An intriguing
puzzle. Trends in Pharmacological Sciences, 40, 171-174.
(403)
TAKAHARA, J., YAMAUCHI, J., NIIMI, M., KAGEYAMA, J., AOKI, Y., FUJINO, K.,
HASHIMOTO, K. & OFUJI, T. (1981) Mechanism of prolactin release by 5‑hydroxytryptophan.
Life Sciences, 29, 1463‑6.
(404) VAN
DE KAR, L.D., KARTESZI, M., BETHEA, C.L. & GANONG, W.F. (1985) Serotonergic
stimulation of prolactin and corticosterone secretion is mediated by different
pathways from the mediobasal hypothalamus. Neuroendocrinology, 41, 380-384.
(405)
WESTENBERG, H.G., VAN PRAAG, H.M., DEJONG, J.T. & THIJSSEN, J.H. (1982)
Postsynaptic serotonergic activity in depressive patients: Evaluation of the
neuroendocrine strategy. Psychiatry Research, 7 (3), 361-371.
(406)
KORSGAARD, S., GERLACH, J. & CHRISTENSSON, E. (1985) Behavioral aspects of
serotonin-dopamine interaction in the monkey. European Journal of Pharmacology,
118, 245-252.
(407)
LOPEZ, F. (1987) Possible direct effect of serotonin on pituitary prolactin
secretion. Hormone Research, 25, 160-170.
(408)
PILOTTE, N.S., PORTER, J.C. (1981) Dopamine in hypophysial portal plasma and
prolactin in systemic plasma of rats treated with 5‑hydroxytryptamine.
Endocrinology, 108(6), 2137‑41.
(409)
KAJI, H., CHIHARA, K., ABE, H., KITA, T., KASHIO, Y. OKIMURA, Y. & FUJITA,
T. (1985) Effect of passive
immunization with antisera to vasoactive intestinal polypeptide and peptide
histidine isoleucine amide on 5‑hydroxy‑l‑tryptophan‑induced
prolactin release in rats.
Endocrinology, 117, 1914‑9.
(410) DEN‑BOER, J.A. & WESTENBERG, H.G.
(1990) Behavioral, neuroendocrine, and biochemical effects of 5‑hydroxytryptophan
administration in panic disorder. Psychiatry Research, 31, 267‑78.
(411)
FULLER, R.W. & SNODDY, H.D. (1980) Effect of serotonin-releasing drugs on
serum corticosterone concentration in rats. Neuroendocrinology, 31, 96-100.
(412)
FULLER, R.W. (1981) Serotonergic stimulation of pituitary-adrenocortical
function in rats. Neuroendocrinology, 32, 118-127.
(413)
SAPUN, D.I., FARAH, J.M. Jr & MUELLER, G.P. (1981) Evidence that a
serotonergic mechanism stimulates the secretion of pituitary beta‑endorphin‑like
immunoreactivity in the rat. Endocrinology, 109(2), 421‑6
(414) MELTZER, H.Y., UBERKOMAN-WIITA, A.,
ROBERTSON, B.J., TRICOU, B.J. & LOWY, M. (1983) Enhanced serum cortisol
response to 5-hydroxytryptophan in depression and mania. Life Sciences, 33,
2541-2549.
(415) PETRAGLIA, F., FACCHINETTI, F., MARTIGNONI,
E., NAPPI, G., VOLPE, A. & GENAZZANI, A.R. (1984) Serotonergic agonists
increase plasma levels of B-endorphin and B-lipotropin in humans. Journal of
Clinical Endocrinology and Metabolism, 59, 1138-1142.
(416)
MUELLER, E.A., MURPHY, D.L. & SUNDERLAND, T. (1985) Neuroendocrine effects
on m-chlorophenylpiperazine, a serotonin agonist, in humans. Journal of
Clinical Endocrinology and Metabolism, 61, 1179-1184.
(417)
BEYER, H.S., PARKER, L., LI, C.H., STUART, D. & SHARP, B.M. (1986)
B-endorphin attenuates the serum cortisol response to exogenous
adrenocorticotropin. Journal of Clinical Endocrinology and Metabolism, 62, 808-811.
(418)
KOYAMA, T., LOWY, M.T. & MELTZER, H.Y. (1987). 5‑Hydroxytryptophan‑induced
cortisol response and CSF 5‑HIAA in depressed patients. American Journal
of Psychiatry, 144(3), 334‑7.
(419)
SACK, D.A., ROSENTHAL, N.E., PARRY, B.L. & WEHR, T.A. Biological Rhythms in Psychiatry. En
Psychopharmacology, The Third Generation of Progress. edited by HY. Meltzer.
pp. 669-685. New York: Raven Press.
(420)
TAKAHASHI, S., KONDO, H, YOSHIMUR, M. & OCHI, Y. (1974) In:
Psychoneuroendocrinology Workshop, Conference International Society of
Psychoneuroendocrinology, pp. 32-48. Citado por Puig-Antich (1987) En
Psychopharmacology, The Third Generation of Progress. edited by HY. Meltzer.
New York: Raven Press.
(421)
MULLER, E.E., BRAMBILLA, F., CAVAGNINI, F. & PERACCHI, M., PANERAI, A.
(1974) Slight effect of L-Tryptophan on growth hormone release in normal human
subjects. J Clin Endocrinol Metab, 39, 1-5.
(422)
LAAKMANN, G., WITTMANN, M., GUGATH, M., MUELLER, O.A., TREUSCH, J., WAHLSTER,
U. & STALLA, G.K. (1984) Effects of psychotropic drugs (desipramine,
chlorimipramine, sulpiride and diazepam on the human HPA axis.
Psychopharmacology, 84, 66-70.
(423)
PUIG-ANTICH, J. (1987) Affective Disorders in Children and Adolescents:
Diagnostic Validity and Psychobiology. En Psychopharmacology, The Third
Generation of Progress (ed. H.Y. Meltzer), pp, 843-859. New York: Raven Press.
(424)
SAKUMA, M. & KNOBIL, E. (1970) Inhibition of endogenous growth hormone
secretion by exogenous growth hormone infusion in the rhesus monkey.
Endocrinology, 86, 890‑4.
(425)
CHALMERS, R.J., BENNIE, E.H., JOHNSON, R.H. & KINNELL, H.G. (1977) The
growth hormone response to insulin induced hypoglycaemia in alcoholics.
Psychological Medicine, 7, 607‑11.
(426) SYVALAHTI, E.K. & KANTO, J.H. (1975)
Serum growth hormone, serum immunoreactive insulin and blood glucose response
to oral and intravenous diazepam in man. International Journal of Clinical
Pharmacology, 12,74-82.
(427)
HINZ, A., LAAKMANN, G..DAFFNER, V.(1990). The simultaneous use of four
releasing Factors Theoretical and Practical Issues. En Neuropsychopharmacology
(ed. W.E.Bunney, H.Hippius et al).
(428)
TARGUM, S.D. & MARSHALL, L.E. (1989) Fenfluramine Provovation of Anxiety in
Patients With Panic Disorder. Psychiatry Research, 28, 295-306.
(429)
KAHN, R.S., WETZLER, S., ASNIS, G.M. & VAN PRAAG, H.M. (1990) The effects
of m-chlorophenylpiperazine in normal subjects: A dose-response study.
Psychopharmacology, 100:339-344.
(430)
NUTT, D.J. & COWEN, P.J. (1987) Diazepam alters brain 5‑HT function
in man: implications for the acute and chronic effects of benzodiazepines.
Psychological Medicine, 17, 601‑7.
(431)
SIEVER, L.J., MURPHY, D.L., SLATER, S., DE‑LA‑VEGA, E. &
LIPPER, S. (1984) Plasma prolactin changes following fenfluramine in depressed
patients compared to controls: an evaluation of central serotonergic
responsivity in depression. Life Sciences, 34, 1029‑39.
(432) LOPEZ‑IBOR, J.J. Jr., SAIZ‑RUIZ,
J., IGLESIAS, L.M.(1988) The fenfluramine challenge test in the affective
spectrum: a possible marker of endogeneity and severity. Pharmacopsychiatry,
21, 9‑14.
(433)
MELTZER, H.Y., WIITA, B.U. & ROBERTSON, A. (1984) Effect of
5-Hydroxytryptophan on Serum Cortisol Levels in Major Affective Disorders.
Enhanced Response in Depression and Mania. Archives of General Psychiatry, 41,
366-374.
(434)
MELTZER, H.Y., PERLINE, R., TRICOU, B.J., LOWY, M. & ROBERTSON, A. (1984)
Effect of 5-hydroxytryptophan on serum cortisol levels in major affective
disorders: II. Relation to suicide, psychosis, and depressive symptoms.
Archives of General Psychiatry, 41, 379-387.
(435)
COCCARO, E.F., SIEVER, I.J., KAVOUSSI, R. et al. (1989). Serotonergic studies
in patients with affective and personality disorders: Correlates with suicidal
and impulsive aggresive behavior. Archives of General Psychiatry, 46, 587-599.
(436) KAHN, R.S., ASNIS, G.M., WELTZER, S. &
VAN PRAAG, H.M. (1988) Neuroendocrine evidence for a serotonin receptor
hypersensitivity in panic disorder. Psychopharmacology, 96, 360-364.
(437)
GELDER, M.G. (1991) New ways of treating panic disorder. Ann Med, 23, 97‑9.
(438)
TYRER, P. (1976) The rol of Bodily Feelings in Anxiety. Oxford, Oxford
University Press.
(439)
GRIEZ, E.J.L., LOUSBERG, H., VAN DEN HOUT, M.A. & VAN DER MOLEN, G. (1987)
CO2 Vulnerability in Panic Disorder. Psychiatry Research, 20, 87-95.
(440)
WYATT, R.J., PORTNOY, B., KUPFER, D.J., SNYDER, F. & ENGELMAN, K. (1971)
Resting catecholamine concentrations in patients with depression and anxiety.
Archives of General Psychiatry, 24, 65.
(441)
CARR, D.B., SHEEHAN, D.V., SURMAN, O.S., et al. (1986). Neuroendocrine
correlates of lactate-induced anxiety and their response to chronic alprazolam
therapy. American Journal of Psychiatry, 143, 483-494.
(442)
CAMERON, O.G., LEE, M.A., CURTIS, G.C. &
MCCANN, D.S. (1987) Endocrine and physiological changes during
"spontaneous" panic attacks. Psychoneuroendocrinology 12 (5), 321-31.
(443) VAN‑PRAAG,
H.M., ASNIS, G.M., KAHN, R.S., BROWN, S.L., KORN, M., FRIEDMAN, J.M. &
WETZLER, S. (1990) Monoamines and abnormal behaviour. A multi‑aminergic
perspective. British Journal of Psychiatry, 157, 723‑34.
(444) GORMAN, J.M., LIEBOWITZ, M.R., FYER, A.J.,
GOETZ, D., CAMPEAS, R.B., FYER, M.R., DAVIES, S.O. & KLEIN, D.F. (1987) An
open trial of fluoxetine in the treatment of panic attacks. Journal of Clinical
Psychopharmacoly, 7, 329-32.
(445)
SHEEHAM, D.V., BALLENGER, J. & JACOBSEN, G. (1980) Treatment of endogenous
anxiety with phobic, hysterical and hypochondriacal symptoms. Archives of
General Psychiatry, 37, 51-59.
(446)
SUGRUE, M.F. (1983) Some effects of chronic antidepressant treatments on rat
brain monoaminergic systems. Journal of Neural Transmission, 57, 281‑95.
(447)
BALLENGER, J.C. (1986) Pharmacotherapy of the panic disorder. Journal of
Clinical Psychiatry, 47, 27-32.
(448)
GEORGE, D.T., ADINOFF, B., RAVITZ, B., NUTT, D.J., DE‑JONG, J.,
BERRETTINI, W., MEFFORD, I.N., COSTA, E. & LINNOILA, M. (1990) A
cerebrospinal fluid study of the pathophysiology of panic disorder associated
with alcoholism.
Acta
Psychiatrica Scandinavica, 82, 1‑7.
(449)
MCINTYRE, I.M., NORMAN, T.R., MARRIOT, P.F. & BURROWS, G.D. (1987) The
pineal hormone melatonin in panic disorder . Journal of Affective Disorders,
12, 203.
(450)
NAMBOODIRI, M.A., SUGDEN, D., KLEIN, D.C. & MEFFORD, I.N.(1983) 5‑hydroxytryptophan
elevates serum melatonin.
Science,
221, 659‑61.
(451)
DEMISCH, K., DEMISCH, L., BOCHNIK, H.J., NICKELSEN, T., ALTHOFF, P.H.,
SCHOFFLING, K. & RIETH, R. (1986) Melatonin and cortisol increase after
fluvoxamine [letter]. British Journal of Clinical Pharmacology, 22, 620‑2.
(452)
CAVALLO, A., RICHARDS, G.E., MEYER, W.J. & WALDROP, R.D. (1987) Evaluation
of 5- hydroxytryptophan administration as a test of pineal function in humans.
Hormone Research, 27, 69-73.
(453)
ROSSI, J. III, SHALEY, T.L. & PANKSEPP, J. (1983) The role of brain
norepinephrine in clonidine suppression of isolation-induced distress in the
domestic chick. Psychopharmacology, 79, 338.
(454)
HENINGER, G.R., CHARNEY, D.S. & PRICE, L.H. (1988) Noradrenergic and
serotonergic receptor system function in panic disorder and depression. Acta
Psychiatrica Scandinavica Supplementum, 341, 138‑50.
(455)
CHARNEY, D.S., HENINGER, G.R., & REDMON, D.E. Jr. (1983) Yohimbine induced
anxiety and increased noradrenergic function in humans: Effects of diazepam and
clonidine. Life Sciences, 33, 19-29.
(456) EX
32) SODERPALM, B., ANDERSSON, L., CARLSSON, M., MODIGH, K. & ERIKSSON, E.
(1987) Serotonergic influence on the growth hormone response to clonidine in
rat. Journal of Neural Transmission, 69, 105‑14.
(457)
NORMAN T.R., JUDD F.K., STAIKOS V. et al. (1990) High affinity platelet (3H)
LSD binding is decreased in panic disorder. Journal of Affective Disorder, 19,
119-123.
(458)
BALON, R., POHL, R., YERAGANI, V. & RAINEY, J. (1987) Platelet serotonin
levels in panic disorder Acta Psychiatrica Scandinavica, 75, 315-317.
(459)
LEWIS, D.A., NOYES, R.J., CORYELL, W. & CLANCY, S. (1985) Tritiated
imipramine binding to platelets is decreased in patients with
agoraphobia.Psychiatry Research, 16, 2-9.
(460)
INNIS, R.B., CHARNEY, D.S. & HENINGER, G.R. (1987) Differential 3H‑imipramine
platelet binding in patients with panic disorder and depression. Psychiatry
Research, 21, 33‑41.
(461) NUTT, D.J. & FRAZER, S. (1987) Platelet
binding studies in panic disorder. Journal of Affective Disorders, 12, 7-11.
(462)
PECKNOLD,J.C. & SURANYI-CADOTTE, B.E. (1986) Panic disorer and depression:
serotonin uptake and 3H -imipramine studies. Clinical Neuropharmacology,
9(Suppl.4), 46-48.
(463)
SCHNEIDER, L.S., MUNJACK,D, SEVERSON, J.A. & PALMER, R. (1987) Platelet 3h
imipramine binding in generalized anxiety disorder, panic disorder, agoraphobia
with panic attacks. Biological Psychiatry, 22, 59-66.
(464)
UHDE, T.W., BERRETINI, W.H, ROY-BYRNE, P.P, BOULENGER, J.P & POST, R.M.
(1987) Platelet 3H-imipramine binding in patients with panic disorder.
Biological Psychiatry, 22, 52-58.
(465)
MANN, J.J., ARANGO, V., MARZUK, P.M., THECCANAT, S. & REIS, D.J. (1989)
Evidence for the 5-HT Hypothesis of Suicide. A Review of Post-mortem Studies.
British Journal of Psychiatry, 155 (suppl.8), 7-14.
(466)
MARAZZITI,D., ROTONDO, A., PLACIDI, G.F. PERUGI, G., CASSANO, G.B., PACIFICI,
G.M. (1988) Binding of imipramine to
platelet membranes is reduced in panic attacks. Fundamental and Clinical
Pharmacology, 2, 69-75.
(467)
SURANYI-CADOTTE, B.E., LAFAILLE, F., SCHWARTZ, G., NAIR, N.P.V. & QUIRION,
R. (1985) Unchanged platelet 3H-imipramine binding in normal subjects after
imipramine administration. Biological Psychiatry, 20, 1237-1240.
(468)
PLENGE, P. & MELLERUP, E.T. (1982), 3H-Imipramine high- affinity binding
sites in rat brain: Effects of imipramine and lithium. Psychopharmacology, 77,
94-97.
(469)
EGRISE, D., DESMEDT, D., SCHOUTENS, A. & MENDLEWICA, J. (1983) Circannual
variations in the density of tritiated imipramine binding sites on blood
platelets in man. Neuropsychobiology, 10, 101-102.
(470)
MENDLEWICZ, J.(1984) Seasonal variation in platelet 3H imipramine binding in
man. Psychiatry Research, 12, 179.
(471)
WHITAKER, P.M., WARSH, I.J., STANCER, H.C., PERSAD, E. & VINT, C.K. (1984)
Seasonal variation in platelet 3H-imipramine binding: Comparable values in
control and depressed populations. Psychiatry Research, 11, 127-131.
(472)
TANG, S.W. & MORRIS, J.M. (1985)
Variations in human platelet 3H-imipramine binding. Psychiatry Research,
16, 131-139.
(473)
GOZIOTIS, A. & TANG, S.W. (1988) A longitudinal study of intact platelet 3H
-imipramine binding in 12 normal human subjects. Psychiatry Research, 26,
157-162.
(474)
WHITAKER, P.M., WARSH, I.J, STANCER, H.C., PERSAD, E. & VINT, C.K. (1984) Seasonal variation in platelet
3H-imipramine binding: Comparable values in control and depressed populations.
Psychiatry Research, 11, 127-131.
(475)
SCHNEIDER, P., EVANS, L., ROSS-LEE, WILTSHIRE, B., EADIE, M., KANARDY, J. &
HOEY, H. (1987) Plasma biogenic amine levels in agoraphobia with panic attacks.
Pharmacopsychiatry, 20, 102-105.
(476)
MENDELS, J. & FRAZER, A. (1974) Brain biogenic amine depletion and mood.
Archives of General Psychiatry, 30, 447‑451.
(477)
BANKI, C.M.(1977) Correlation of anxiaty and related symptoms with
cerebrospinal fluid 5- hydroxyindolacetic acid in depressed women. Journal of
Neural Transmission, 41:135-43.
(478)
CAMERON, O.G., SMITH, C.B., HOLLINGSWORTH, P.J., NESSE, R.M. & CURTIS, G.C.
(1984) Platelet alpha 2- adrenergic
receptor binding and plasma catecholamines before and during imipramine
treatment in patients with panic anxiety. Archives of General Psychiatry, 41,
1144-1148.
(479)
WYATT, R.J., PORTNOY, B., KUPFER, D.J., SNYDER, F. & ENGELMAN, K. (1971)
Resting catecholamine concentrations in patients with depression and anxiety.
Archives of General Psychiatry, 24, 65.
(480)
DIMSDALE, J.E. & MOSS, J. (1980) Plasma catecholamines in stress and
exercise. JAMA, 243, 340-342.
(481)
LIEBOWITZ, M.R., GORMAN, J.M., FYER, A.J. et al (1985) Lactate provocation of
panic attacks:i. Clinical and behavioral findings. Archives of General
Psychiatry, 42, 709-719.
(482)
ERIKSSON, E., WESTBERG, P., ALLING, C. THURESSON, K. & MODIGH, K. (1991)
Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
Psychiatry Research, 36, 243‑51.
(483)
HAMLIN, C.L., LYDIARD, R.B., MARTIN, D., DACKIS, C.A., POTTASH, A.C., SWEENEY,
D. & GOLD, M.S. (1983) Urinary excretion of noradrenaline metabolite
decreased in panic disorder (letter) Lancet, 24, 740-1.
(484)
UHDE, T.W., VITTONE, B.J. & POST, R.M. (1984) Glucose tolerance testing in
panic disorder. American Journal of Psychiatry 141, 1461.
(485)
CAMERON, O.G., LEE, M.A., CURTIS, G.C. & MCCANN, D.S. (1985) Endocrine and
physiological changes during "spontaneous" panic attacks.
Psychoneuroendocrinology, 12, 321.
(486)
TANG, S.W. & MORRIS, J.M. (1985) Variations in human platelet 3H-imipramine
binding. Psychiatry Research, 16, 131-139.
(487) KO,
G.N., ELSWORTH, J.D., ROTH, R.H., et al: Panic-induced elevation of plasma MHPG
levels in phobic-anxious patients. Archives of General Psychiatry, 40,
425,1983.
(488) MACKENZIE,
E.T., MCCULLOCH, J., O'KEANE, M., PICKARD, J.D. & HARPER, A.M. (1976)
Cerebral circulation and norepinephrine: Relevance of the blood-brain barrier.
American Journal of Physiology, 231, 483.
(489)
HARBEDO, J.L. & OWMAN, C. (1980) Barrier mechanisms for neurotransmitter
monoamines and their precursors at the blood-brain interface. Annals of
Neurology, 8, 1.
(490)
NOYES, R. Jr., ANDERSON, D.J., CLANCY J, CROWE RR, SLYMEN D, GHOBNEIM MM,
HINRICHS J, (1984) Diazepam and propranolol in panic disorder and agoraphobia.
Archives of General Psychiatry, 41, 287-292.
(491)
GORMAN, J.M., LEVY, G.F., LIEBOWITZ, M.R., MCGRATH, P., APPLEBY, I., DILLON,
D., DAVIES, S.O. & KLEIN, D.F. (1983) Intravenous propranolol during sodium
lactate infusion. Psychopharmacology Bulletin, 19, 577-578.
(492)
JACOBS, B.C., HEYM, J. & STEINFELS, G.F. (1984) Physiological and
behavioural analysis of raphe unit activity. In Handbook of psychopharmacology
(eds. L.L.Iversen, S.D. Iversen & S.H. Snyder), p. 343. Plenum Press.
(493) SOUBRIE,
P. (1986). Reconciling the role of central serotonin neurons in human and
animal behaviour. Behavioural and Brain Sciences, 9, 319.
(494)
Bunney, W.E. Jr. & Garland-BUNNEY, B.L. (1987) Mechanisms of Action of
Lithium in Affective Illness: Basic and Clinical Implications. En
Psychopharmacology, The Third Generation of Progress. edited by HY. Meltzer.
pp.553-565. New York: Raven Press.
(495)
MARSDEN CA. Neurofarmacología de la serotonina en el SNC. In Feighner JP, Boyer
WF. Inhibidores selectivos de la Recaptación de serotonina. Wiley 1991.
496)
BLIER, P., CHAPUT, Y. & DEMONTIGNY, C. (1988) Long-term 5-Ht reuptake
blockade, but not monoamine oxidase inhibition, decreases the function of
terminal 5-Ht autoreceptors: an electrophysiological study in the rat brain.
Naunym-Schmiedebergs Archives of Pharmacology, 337: 246-254.
(497)
PEROUTKA, S.J., SCHMIDT, A.W., SLEIGHT, A.J., HARRINGTON, M.A.(1989) Serotonin
receptor "families" in the central nervous system: an overview.
Annals of the New York Academy of Sciences, 600, 104-112.
(498)
VERGÉ d, dAVAL g, Patey A et al. 1985. Presynaptic 5-HT autoreceptors on
serotonergic cell bodies and/or dendrites but not terminal are of the 5-HT1A
sub-type. European Journal of Pharmacology 113, 463-464)
(499)
Weissman-Nanopoulous D, Mach E, Magre J et al. 1985. Evidence for the
localisation of 5-HT1A binding sites on serotonin-containing neurones in the
raphé dorsalis and raphé centralis nuclei of the rat brain. Neuroscience 17,
1061-1072.
(500)
Blier P and Montigny C. 1987. Modification of 5-HT neuron properties by
sustained administration of the 5-HT1A agonist, gepirone: an
electrophysiological study in rat brain. Synapse 1, 470-480.
(501)
Graeff FG, Zuardi AW, Giglio JS, Lima Filho EC, Karniol IG (1985) Effect of
metergoline on human anxiety. Psychopharmacology, 86, 334.
(502)
Frazer GA, Lapierre YD (1987). The effect of buspirone on panic disorder; a
case report. Journal of Clinical Psychopharmacology, 7, 118.
(503) VAN
DER kAR LD, Karteszi M, Bethea CL, and Ganong, WF. 1985: Neuroendocrinology,
41: 380-384. citado por Meltzer, H.Y & Lowy, M.T.(1987) en
Psychopharmacology.(ed H.Y. Meltzer). Raven Press. New York.
(504)
WILSON, J.D. (1989) Trastornos endocrinos de la mama.En Harrison: Principios de
Medicina Interna, 11ª edición (7ªedición en español), pp. 2235-39 (eds. E.
Braunwald, K.J.Isselbacher, R.G.Petersdorf, J.D. Wilson, J.B. Martin &
A.S.Fauci). Interamericana, McGraw-Hill.
(505)
INGBAR, S.H. (1989) Enfermedades tiroideas. En Harrison: Principios de Medicina
Interna, 11ª edición (7ªedición en español), pp.2116-2139 (eds. E. Braunwald,
K.J.Isselbacher, R.G.Petersdorf, J.D. Wilson, J.B. Martin & A.S.Fauci).
Interamericana, McGraw-Hill.
(506)
LOOSEN, P.T. (1985) The TRH-induced TSH response in psychiatric patients: a
possible neuroendocrine marker. Psycgoneuroendocrinology, 10, 237.
(507)
GOLDEN, R.N., HSIAO, J.K., LANE, E., EKSTROM, D., ROGERS, S., HICKS, R. &
POTTER, W.Z. (1990) Abnormal neuroendocrine responsivity to acute i.v.
clomipramine challenge in
depressed
patients. Psychiatry Research, 31, 39‑47.
(508)
BALLENGER, J.C. (1987) Unrecognized prevalence of panic disorder in primary
care, internal medicine and cardiology.
American
Journal of Cardiology, 60, 39J‑47J.
(509)
BROWN, R., MUNJACK, D. & MCDOWELL, D. (1989) Agoraphobia with and without
current panic attacks. Psychol Rep, 64, 503‑506.
(510)
RASKIN, M., PEEKE, H.V., DICKMAN, W. & PINSKER, H. (1982) Panic and
generalized anxiety disorder. Developmental antecedents and precipitants.
Archives of General Psychiatry, 39, 687-689.
(511)
BELL, I.R., JASNOSKI, M.L., KAGAN, J. & KING, D.S. (1990)
Is
allergic rhinitis more frequent in young adults with extreme shyness? A
preliminary survey. Psychosomatic Medicine, 52, 517‑25.